Digital ulcers in patients with systemic sclerosis
Chung, L., & Fiorentino, D. (2006). Digital ulcers in patients with systemic sclerosis. AUTOIMMUNITY REVIEWS, 5(2), 125–28.

A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis
Chung, L., & Fiorentino, D. (2006). A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 54(5), 880–82.

Coronary artery disease in patients with systemic lupus erythematosus
Galindo, M., Chung, L., Crockett, S. D., & Chakravarty, E. F. (2005). Coronary artery disease in patients with systemic lupus erythematosus. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 1(1), 55–59.

Systemic and locatized scleroderma
Chung, L., Lin, J., Furst, D. E., & Fiorentino, D. (2006). Systemic and locatized scleroderma. CLINICS IN DERMATOLOGY, 24(5), 374–92.

Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease
Chung, L., Flyckt, R. L. R., Colon, I., Shah, A. A., Druzin, M., & Chakravarty, E. F. (2006). Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease. LUPUS, 15(9), 595–599.

Successful use of rituximab for cutaneous vasculitis
Chung, L., Funke, A. A., Chakravarty, E. F., Callen, J. P., & Fiorentino, D. F. (2006). Successful use of rituximab for cutaneous vasculitis. ARCHIVES OF DERMATOLOGY, 142(11), 1407–10.

A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands
Magnano, M. D., Chakravarty, E. F., Broudy, C., Chung, L., Kelman, A., Hillygus, J., & Genovese, M. C. (2007). A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. JOURNAL OF RHEUMATOLOGY, 34(6), 1323–27.

Therapeutic options for digital ulcers in patients with systemic sclerosis.
Chung, L. (2007). Therapeutic options for digital ulcers in patients with systemic sclerosis. Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 5(6), 460–65.

A pilot trial of rituximab in the treatment of patients with dermatomyositis
Chung, L., Genovese, M. C., & Fiorentino, D. F. (2007). A pilot trial of rituximab in the treatment of patients with dermatomyositis. ARCHIVES OF DERMATOLOGY, 143(6), 763–67.

Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample
Chung, L., Krishnan, E., & Chakravarty, E. F. (2007). Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample. RHEUMATOLOGY, 46(12), 1808–1813.

Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease
Chakravarty, E. F., Khanna, D., & Chung, L. (2008). Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease. OBSTETRICS AND GYNECOLOGY, 111(4), 927–34.

Malignancy in the Setting of the Anti-Synthetase Syndrome
Rozelle, A., Trieu, S., & Chung, L. (2008). Malignancy in the Setting of the Anti-Synthetase Syndrome. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 14(5), 285–88.

Molecular Framework for Response to Imatinib Mesylate in Systemic Sclerosis
Chung, L., Fiorentino, D. F., Benbarak, M. J., Adler, A. S., Mariano, M. M., Paniagua, R. T., … Robinson, W. H. (2009). Molecular Framework for Response to Imatinib Mesylate in Systemic Sclerosis. ARTHRITIS AND RHEUMATISM, 60(2), 584–91.

MQX-503, a Novel Formulation of Nitroglycerin, Improves the Severity of Raynaud's Phenomenon A Randomized, Controlled Trial
Chung, L., Shapiro, L., Fiorentino, D., Baron, M., Shanahan, J., Sule, S., … Wigley, F. M. (2009). MQX-503, a Novel Formulation of Nitroglycerin, Improves the Severity of Raynaud's Phenomenon A Randomized, Controlled Trial. ARTHRITIS AND RHEUMATISM, 60(3), 870–77.

Characterizing systemic sclerosis in Northern California: focus on Asian and Hispanic patients.
Schmajuk, G., Bush, T. M., Burkham, J., Krishnan, E., & Chung, L. (2009). Characterizing systemic sclerosis in Northern California: focus on Asian and Hispanic patients. Clinical and Experimental Rheumatology, 27(3), 22–25.

A 39-Year-Old Woman With Lupus, Myositis, and a Recalcitrant Vasculopathy
Sokolove, J., Copland, A., Shirvani, S., Brown, J., Posley, K., & Chung, L. (2010). A 39-Year-Old Woman With Lupus, Myositis, and a Recalcitrant Vasculopathy. ARTHRITIS CARE & RESEARCH, 62(9), 1351–56.

Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL Identifying Systemic Sclerosis as a Unique Phenotype
Chung, L., Liu, J., Parsons, L., Hassoun, P. M., McGoon, M., Badesch, D. B., … Zamanian, R. T. (2010). Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL Identifying Systemic Sclerosis as a Unique Phenotype. CHEST, 138(6), 1383–94.

Tyrosine kinases in inflammatory dermatologic disease
Paniagua, R. T., Fiorentino, D. F., Chung, L., & Robinson, W. H. (2011). Tyrosine kinases in inflammatory dermatologic disease. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 65(2), 389–403.

Digital ischemic loss in systemic sclerosis.
Marvi, U., & Chung, L. (2010). Digital ischemic loss in systemic sclerosis. International Journal of Rheumatology, 2010.

Vascular disease in systemic sclerosis.
Chung, L., Distler, O., Hummers, L., Krishnan, E., & Steen, V. (2010). Vascular disease in systemic sclerosis. International Journal of Rheumatology, 2010, 714172-?

Colonic ulceration as an unusual manifestation of vasculopathy in systemic sclerosis
Kao, L., Myer, P., Nguyen, L., Zamanian, R. T., & Chung, L. (2011). Colonic ulceration as an unusual manifestation of vasculopathy in systemic sclerosis. RHEUMATOLOGY, 50(3), 626–28.

An Analysis of Connective Tissue Disease-associated Interstitial Lung Disease at a US Tertiary Care Center: Better Survival in Patients with Systemic Sclerosis
Su, R., Bennett, M., Jacobs, S., Hunter, T., Bailey, C., Krishnan, E., … Chung, L. (2011). An Analysis of Connective Tissue Disease-associated Interstitial Lung Disease at a US Tertiary Care Center: Better Survival in Patients with Systemic Sclerosis. JOURNAL OF RHEUMATOLOGY, 38(4), 693–701.

Pathogenesis of dermatomyositis: role of cytokines and interferon.
Kao, L., Chung, L., & Fiorentino, D. F. (2011). Pathogenesis of dermatomyositis: role of cytokines and interferon. Current Rheumatology Reports, 13(3), 225–32.

Hyperuricemia and the risk for subclinical coronary atherosclerosis - data from a prospective observational cohort study
Krishnan, E., Pandya, B. J., Chung, L., & Dabbous, O. (2011). Hyperuricemia and the risk for subclinical coronary atherosclerosis - data from a prospective observational cohort study. ARTHRITIS RESEARCH & THERAPY, 13(2).

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study
Fiorentino, D., Chung, L., Zwerner, J., Rosen, A., & Casciola-Rosen, L. (2011). The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 65(1), 25–34.

Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis.
Arefiev, K., Fiorentino, D. F., & Chung, L. (2011). Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis. International Journal of Rheumatology, 2011, 201787-?

Systemic sclerosis 2011.
Chung, L., Distler, O., Hummers, L., Krishnan, E., & Steen, V. (2011). Systemic sclerosis 2011. International Journal of Rheumatology, 2011, 308231-?

Clinical trial design in scleroderma: where are we and where do we go next?
Chung, L., Denton, C. P., Distler, O., Furst, D. E., Khanna, D., & Merkel, P. A. (2012). Clinical trial design in scleroderma: where are we and where do we go next? CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 30(2), S97–S102.

Hyperuricemia in Young Adults and Risk of Insulin Resistance, Prediabetes, and Diabetes: A 15-Year Follow-up Study
Krishnan, E., Pandya, B. J., Chung, L., Hariri, A., & Dabbous, O. (2012). Hyperuricemia in Young Adults and Risk of Insulin Resistance, Prediabetes, and Diabetes: A 15-Year Follow-up Study. AMERICAN JOURNAL OF EPIDEMIOLOGY, 176(2), 108–16.

Dyspnea Assessment and Pulmonary Hypertension in Patients With Systemic Sclerosis: Utility of the University of California, San Diego, Shortness of Breath Questionnaire
Chung, L., Chen, H., Khanna, D., & Steen, V. D. (2013). Dyspnea Assessment and Pulmonary Hypertension in Patients With Systemic Sclerosis: Utility of the University of California, San Diego, Shortness of Breath Questionnaire. ARTHRITIS CARE & RESEARCH, 65(3), 454–63.

Clinical presentation and evaluation of dermatomyositis.
Marvi, U., Chung, L., & Fiorentino, D. F. (2012). Clinical presentation and evaluation of dermatomyositis. Indian Journal of Dermatology, 57(5), 375–81.

Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis.
Yaqub, A., & Chung, L. (2013). Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis. Current Rheumatology Reports, 15(1), 302-?

Functional Class Improvement and 3-Year Survival Outcomes in Patients With Pulmonary Arterial Hypertension in the REVEAL Registry
Barst, R. J., Chung, L., Zamanian, R. T., Turner, M., & Mcgoon, M. D. (2013). Functional Class Improvement and 3-Year Survival Outcomes in Patients With Pulmonary Arterial Hypertension in the REVEAL Registry. CHEST, 144(1), 160–68.

Management of the hand in systemic sclerosis.
Fox, P., Chung, L., & Chang, J. (2013). Management of the hand in systemic sclerosis. Journal of Hand Surgery, 38(5), 1012–16.

Localized cutaneous fibrosing disorders.
Yaqub, A., Chung, L., Rieger, K. E., & Fiorentino, D. F. (2013). Localized cutaneous fibrosing disorders. Rheumatic Diseases Clinics of North America, 39(2), 347–64.

Incidence of bleeding complications in patients on celecoxib and warfarin.
Chung, L., Wang, C., Kearns, P., Chakravarty, E. F., & Bush, T. M. (2004). Incidence of bleeding complications in patients on celecoxib and warfarin. ARTHRITIS AND RHEUMATISM, 50(12), 4087–88.

Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease.
Chung, L., Flyckt, R. L. R., Colon, I., Shah, A. A., Drusin, M., & Chakravarty, E. F. (2006). Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease. ARTHRITIS AND RHEUMATISM, 54(12), 4077–77.

Survival in Pulmonary Hypertension Registries The Importance of Incident Cases Response
Chung, L., Liu, J., Parsons, L. S., Hassoun, P. M., McGoon, M. D., Badesch, D. B., … Zamanian, R. T. (2011). Survival in Pulmonary Hypertension Registries The Importance of Incident Cases Response. CHEST, 139(6), 1548–49.

A Pilot Study of Abatacept for the Treatment of Patients with Diffuse Cutaneous Systemic Sclerosis.
Chakravarty, E. F., Fiorentino, D., Bennett, M., & Chung, L. (2011). A Pilot Study of Abatacept for the Treatment of Patients with Diffuse Cutaneous Systemic Sclerosis. ARTHRITIS AND RHEUMATISM, 63(10), S274–S275.

Molecular framework for response to imatinib mesylate in systemic sclerosis
Chung, L., Fiorentino, D. F., Benbarak, M. J., Adler, A. S., Mariano, M. M., Paniagua, R. T., … Robinson, W. H. (2008). Molecular framework for response to imatinib mesylate in systemic sclerosis. ARTHRITIS AND RHEUMATISM. SAN FRANCISCO,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: WILEY-BLACKWELL.

Evaluation of an imatinib response gene signature in patients with systemic sclerosis
Chung, L., Ruiz, P., Wood, T., Shoor, S., Robinson, W., Whitfield, M., … Fiorentino, D. (2010). Evaluation of an imatinib response gene signature in patients with systemic sclerosis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. CLINICAL & EXPER RHEUMATOLOGY.

A pilot study of TNF inhibition in Erosive/Inflammatory osteoarthritis of the hands.
Magnano, M. D., Chakravarty, E. F., Broudy, C., Chung, L., Kelman, A., Hillygus, J. J., & Genovese, M. C. (2006). A pilot study of TNF inhibition in Erosive/Inflammatory osteoarthritis of the hands. ARTHRITIS AND RHEUMATISM, 54(9), S674–S674.

Immune Responses to NXP-2 and TIF-g Are Associated with Distinct Clinical Phenotypes and Prognosis for Skin Disease in Dermatomyositis Patients.
Fiorentino, D., Chung, L., Zaba, L., Lingala, B., Rosen, A., & Casciola-Rosen, L. (2012). Immune Responses to NXP-2 and TIF-g Are Associated with Distinct Clinical Phenotypes and Prognosis for Skin Disease in Dermatomyositis Patients. ARTHRITIS AND RHEUMATISM, 64(10), S828–S828.

Molecular Profiling to Diagnose a Case of Atypical Dermatomyositis.
Molecular Profiling to Diagnose a Case of Atypical Dermatomyositis. (2013). The Journal of Investigative Dermatology.

Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry
Bae, S., Saggar, R., Bolster, M. B., Chung, L., Csuka, M. E., Derk, C., … Khanna, D. (2012). Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry. ANNALS OF THE RHEUMATIC DISEASES, 71(8), 1335–42.

Characterizing systemic sclerosis in Northern California: focus on Asian and Hispanic patients
Schmajuk, G., Bush, T. M., Burkham, J., Krishnan, E., & Chung, L. (2009). Characterizing systemic sclerosis in Northern California: focus on Asian and Hispanic patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 27(3), S22–S25.

Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey
Linos, E., Fiorentino, D., Lingala, B., Krishnan, E., & Chung, L. (2013). Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey. ARTHRITIS RESEARCH & THERAPY, 15(1).

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise
Fransen, J., Johnson, S. R., van den Hoogen, F., Baron, M., Allanore, Y., Carreira, P. E., … Khanna, D. (2012). Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. ARTHRITIS CARE & RESEARCH, 64(3), 351–57.

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1?.
Fiorentino, D. F., Chung, L. S., Christopher-Stine, L., Zaba, L., Li, S., Mammen, A. L., … Casciola-Rosen, L. (2013). Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1?. Arthritis and Rheumatism, 65(11), 2954–62.

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., … Pope, J. E. (2013). 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. ANNALS OF THE RHEUMATIC DISEASES, 72(11), 1747–55.

Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1?.
Fiorentino, D. F., Chung, L. S., Christopher-Stine, L., Zaba, L., Li, S., Mammen, A. L., … Casciola-Rosen, L. (2013). Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1?. Arthritis and Rheumatism, 65(11), 2954–62.

2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., … Pope, J. E. (2013). 2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. ARTHRITIS AND RHEUMATISM, 65(11), 2737–47.

Atherosclerotic Cardiovascular Disease in Hospitalized Patients With Systemic Sclerosis: Higher Mortality Than Patients With Lupus and Rheumatoid Arthritis
Dave, A. J., Fiorentino, D., Lingala, B., Krishnan, E., & Chung, L. (2014). Atherosclerotic Cardiovascular Disease in Hospitalized Patients With Systemic Sclerosis: Higher Mortality Than Patients With Lupus and Rheumatoid Arthritis. ARTHRITIS CARE & RESEARCH, 66(2), 323–27.

Recommendations for Screening and Detection of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Khanna, D., Gladue, H., Channick, R., Chung, L., Distler, O., Furst, D. E., … McLaughlin, V. V. (2013). Recommendations for Screening and Detection of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. ARTHRITIS AND RHEUMATISM, 65(12), 3194–3201.

Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis
Baron, M., Chung, L., Gyger, G., Hummers, L., Khanna, D., Mayes, M. D., … Hudson, M. (2014). Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis. CLINICAL RHEUMATOLOGY, 33(2), 207–14.

Survival and Predictors of Mortality in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry
Chung, L., Domsic, R. T., Lingala, B., Alkassab, F., Bolster, M., Csuka, M. E., … Steen, V. D. (2014). Survival and Predictors of Mortality in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry. ARTHRITIS CARE & RESEARCH, 66(3), 489–95.

International consensus criteria for the diagnosis of Raynaud's phenomenon.
Maverakis, E., Patel, F., Kronenberg, D. G., Chung, L., Fiorentino, D., Allanore, Y., … Gershwin, M. E. (2014). International consensus criteria for the diagnosis of Raynaud's phenomenon. Journal of Autoimmunity, 48-49, 60–65.

Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria
Johnson, S. R., Naden, R. P., Fransen, J., van den Hoogen, F., Pope, J. E., Baron, M., … Khanna, D. (2014). Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria. JOURNAL OF CLINICAL EPIDEMIOLOGY, 67(6), 706–14.

Cardiac arrhythmias and conduction defects in systemic sclerosis
Vacca, A., Meune, C., Gordon, J., Chung, L., Proudman, S., Assassi, S., … Allanore, Y. (2014). Cardiac arrhythmias and conduction defects in systemic sclerosis. RHEUMATOLOGY, 53(7), 1172–77.

Localized cutaneous fibrosing disorders.
Yaqub, A., Chung, L., Rieger, K. E., & Fiorentino, D. F. (2013). Localized cutaneous fibrosing disorders. Rheumatic Diseases Clinics of North America, 39(2), 347–364.

Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.
Valenzuela, A., Chung, L., Casciola-Rosen, L., & Fiorentino, D. (2014). Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis. JAMA Dermatology, 150(7), 724–29.

Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: Results of a prospective pilot study.
Chung, L., Ball, K., Yaqub, A., Lingala, B., & Fiorentino, D. (2014). Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: Results of a prospective pilot study. Journal of the American Academy of Dermatology, 71(2), 400–401.

Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry.
Chung, L., Farber, H. W., Benza, R., Miller, D. P., Parsons, L., Hassoun, P. M., … Zamanian, R. T. (2014). Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry. Chest, 146(6), 1494–1504.

Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study.
Hsu, V. M., Chung, L., Hummers, L. K., Wigley, F., Simms, R., Bolster, M., … Steen, V. D. (2014). Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. Seminars in Arthritis and Rheumatism, 44(1), 55–62.

Validation of a Novel Radiographic Scoring System for Calcinosis Affecting the Hands of Patients With Systemic Sclerosis
Chung, L., Valenzuela, A., Fiorentino, D., Stevens, K., Li, S., Harris, J., … Baron, M. (2015). Validation of a Novel Radiographic Scoring System for Calcinosis Affecting the Hands of Patients With Systemic Sclerosis. ARTHRITIS CARE & RESEARCH, 67(3), 425–30.

Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters
Fischer, A., Swigris, J. J., Bolster, M. B., Chung, L., Csuka, M. E., Domsic, R. T., … Steen, V. D. (2014). Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 32(6), S109–S114.

Cutaneous vasculitis
Chung, L., & Fiorentino, D. (2005). Cutaneous vasculitis. Orphanet Encyclopedia, (March).

Systemic and localized scleroderma
Chung, L., Lin, J., Furst, D., & Fiorentino, D. (2006). Systemic and localized scleroderma. Clinics in Dermatology, 24(5).

Current and future trends in systemic lupus erythematosus
Chung, L. (2006). Current and future trends in systemic lupus erythematosus. The Rheumatology Report, 1(2).

Emerging therapies in systemic sclerosis
Chung, L., Distler, O., Hummers, L., Krishnan, E., & Steen, V. (2011). Emerging therapies in systemic sclerosis. International Joural of Rheumatology.

Cutaneous Vasculitis
Chung, L., Kea, B., & Fiorentino, D. (2008). Cutaneous Vasculitis. Dermatology (pp. 347–367). Mosby.

Pulmonary arterial hypertension in systemic sclerosis
Chung, L., Zamanian, R. T., & Ghofrani, H. A. (2009). Pulmonary arterial hypertension in systemic sclerosis. Scleroderma: Modern aspects of pathogenesis, diagnosis and therapy (pp. 37–43). Unimed Publishers.

Classification and Diagnosis of Systemic Slerosis: Towards Early Recognition of the Disease
Chung, L., Fransen, J., & van den Hoogen, F. (2012). Classification and Diagnosis of Systemic Slerosis: Towards Early Recognition of the Disease. Scleroderma: From Pathogenesis to Comprehensive Management (pp. 53–69). Dordrecht, Heidelberg, London, Springer.

Management of digital ischemia
Chung, L., Valenzuela, A., & Adeduntan, R. (2015). Management of digital ischemia. Raynaud's Phenomenon: A Guide to Pathogenesis and Treatment (pp. 339–360). Heidelberg, Dordrecht, London, Springer.

Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters.
Fischer, A., Swigris, J. J., Bolster, M. B., Chung, L., Csuka, M. E., Domsic, R., … Steen, V. D. (2014). Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters. Clinical and Experimental Rheumatology, 32(6), S-109 14.

Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1? antibodies in adults with dermatomyositis.
Fiorentino, D. F., Kuo, K., Chung, L., Zaba, L., Li, S., & Casciola-Rosen, L. (2015). Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1? antibodies in adults with dermatomyositis. Journal of the American Academy of Dermatology, 72(3), 449–55.

Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults CHEST Guideline and Expert Panel Report
Taichman, D. B., Ornelas, J., Chung, L., Klinger, J. R., Lewis, S., Mandel, J., … Badesch, D. B. (2014). Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults CHEST Guideline and Expert Panel Report. CHEST, 146(2), 449–75.

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Sung, Y. K., & Chung, L. (2015). Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 41(2), 295-?

Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease.
Narang, N. S., Casciola-Rosen, L., Li, S., Chung, L., & Fiorentino, D. F. (2015). Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease. Arthritis Care & Research, 67(5), 667–72.

Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.
Valenzuela, A., Nandagopal, S., Steen, V. D., & Chung, L. (2015). Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis. Rheumatic Diseases Clinics of North America, 41(3), 489–506.

Surgical treatment of systemic sclerosis-is it justified to offer peripheral sympathectomy earlier in the disease process?
Momeni, A., Sorice, S. C., Valenzuela, A., Fiorentino, D. F., Chung, L., & Chang, J. (2015). Surgical treatment of systemic sclerosis-is it justified to offer peripheral sympathectomy earlier in the disease process? Microsurgery, 35(6), 441–46.

Validation of the ICD-9-CM code for systemic sclerosis using updated ACR/EULAR classification criteria
VALENZUELA, A., Yaqub, A., Fiorentino, D., Krishnan, E., & Chung, L. (2015). Validation of the ICD-9-CM code for systemic sclerosis using updated ACR/EULAR classification criteria. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 44(3), 253–255.

Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis.
Chakravarty, E. F., Martyanov, V., Fiorentino, D., Wood, T. A., Haddon, D. J., Jarrell, J. A., … Chung, L. (2015). Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis. Arthritis Research & Therapy, 17, 159-?

Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.
Valenzuela, A., Chung, L., Casciola-Rosen, L., & Fiorentino, D. (2014). Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis. JAMA Dermatology, 150(7), 724–29.

Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
Chakravarty, E. F., Martyanov, V., Fiorentino, D., Wood, T. A., Haddon, D. J., Jarrell, J. A., … Chung, L. (2015). Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis. ARTHRITIS RESEARCH & THERAPY, 17.

Connective tissue disease-associated pulmonary arterial hypertension.
Sung, Y. K., & Chung, L. (2015). Connective tissue disease-associated pulmonary arterial hypertension. Rheumatic Diseases Clinics of North America, 41(2), 295–313.

Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry.
Chung, L., Domsic, R. T., Lingala, B., Alkassab, F., Bolster, M., Csuka, M. E., … Steen, V. D. (2014). Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. Arthritis Care & Research, 66(3), 489–495.

Cardiac arrhythmias and conduction defects in systemic sclerosis.
Vacca, A., Meune, C., Gordon, J., Chung, L., Proudman, S., Assassi, S., … Allanore, Y. (2014). Cardiac arrhythmias and conduction defects in systemic sclerosis. Rheumatology , 53(7), 1172–77.

Leukotriene B-4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension
Qian, J., Tian, W., Jiang, X., Tamosiuniene, R., Sung, Y. K., Shuffle, E. M., … Nicolls, M. R. (2015). Leukotriene B-4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension. HYPERTENSION, 66(6), 1227–39.

Digital Sympathectomy in Patients With Scleroderma: An Overview of the Practice and Referral Patterns and Perceptions of Rheumatologists.
Chiou, G., Crowe, C., Suarez, P., Chung, L., Curtin, C., & Chang, J. (2015). Digital Sympathectomy in Patients With Scleroderma: An Overview of the Practice and Referral Patterns and Perceptions of Rheumatologists. Annals of Plastic Surgery, 75(6), 637–43.

Corticosteroids in Myositis and Scleroderma.
Postolova, A., Chen, J. K., & Chung, L. (2016). Corticosteroids in Myositis and Scleroderma. Rheumatic Diseases Clinics of North America, 42(1), 103–18.

Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change
Anyanwu, C. O., Fiorentino, D. F., Chung, L., Dzuong, C., Wang, Y., Okawa, J., … Werth, V. P. (2015). Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change. BRITISH JOURNAL OF DERMATOLOGY, 173(4), 969–74.

Corticosteroids in Myositis and Scleroderma.
Postolova, A., Chen, J. K., & Chung, L. (2016). Corticosteroids in Myositis and Scleroderma. Rheumatic Diseases Clinics of North America, 42(1), 103–18.

Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry
Hinchcliff, M., Khanna, S., Hsu, V. M., Lee, J., Almagor, O., Chang, R. W., … Chung, L. (2015). Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry. SEMINARS IN ARTHRITIS AND RHEUMATISM, 45(3), 309–14.

Calcinosis: pathophysiology and management.
Valenzuela, A., & Chung, L. (2015). Calcinosis: pathophysiology and management. Current Opinion in Rheumatology, 27(6), 542–48.

Intestinal pseudo-obstruction in patients with systemic sclerosis: an analysis of the Nationwide Inpatient Sample.
Valenzuela, A., Li, S., Becker, L., Fernandez-Becker, N., Khanna, D., Nguyen, L., & Chung, L. (2016). Intestinal pseudo-obstruction in patients with systemic sclerosis: an analysis of the Nationwide Inpatient Sample. Rheumatology , 55(4), 654–58.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials
Saketkoo, L. A., Mittoo, S., Huscher, D., Khanna, D., Dellaripa, P. F., Distler, O., … Seibold, J. R. (2014). Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials. THORAX, 69(5), 428–36.

Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease-related Interstitial Lung Diseases
Saketkoo, L. A., Mittoo, S., Frankel, S., LeSage, D., Sarver, C., Phillips, K., … Matteson, E. L. (2014). Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease-related Interstitial Lung Diseases. JOURNAL OF RHEUMATOLOGY, 41(4), 792–98.

Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study
Valenzuela, A., Baron, M., Herrick, A. L., Proudman, S., Stevens, W., Rodriguez-Reyna, T. S., … Chung, L. (2016). Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study. SEMINARS IN ARTHRITIS AND RHEUMATISM, 46(3), 344–49.

Abstract 46: surgical treatment of systemic sclerosis: re-thinking the role and timing of peripheral sympathectomy.
Momeni, A., Sorice, S. C., Valenzuela, A., Fiorentino, D. F., Chung, L., & Chang, J. (2014). Abstract 46: surgical treatment of systemic sclerosis: re-thinking the role and timing of peripheral sympathectomy. Plastic and Reconstructive Surgery, 133(4), 1010-?

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Khanna, D., Denton, C. P., Jahreis, A., van Laar, J. M., Frech, T. M., Anderson, M. E., … Furst, D. E. (2016). Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. LANCET, 387(10038), 2630–40.

An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial.
Khanna, D., Albera, C., Fischer, A., Khalidi, N., Raghu, G., Chung, L., … Gorina, E. (2016). An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial. Journal of Rheumatology, 43(9), 1672–79.

Pathogenesis of Dermatomyositis: Role of Cytokines and Interferon
Kao, L., Chung, L., & Fiorentino, D. F. (2011). Pathogenesis of Dermatomyositis: Role of Cytokines and Interferon. CURRENT RHEUMATOLOGY REPORTS, 13(3), 225–32.

Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
Chung, L., Fairchild, R. M., Furst, D. E., Li, S., Alkassab, F., Bolster, M. B., … Zamanian, R. T. (2016). Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry. Clinical and Experimental Rheumatology, -?

The cutaneous and systemic findings associated with nuclear matrix protein-2 antibodies in adult dermatomyositis patients.
Rogers, A., Chung, L., Li, S., Casciola-Rosen, L., & Fiorentino, D. F. (2017). The cutaneous and systemic findings associated with nuclear matrix protein-2 antibodies in adult dermatomyositis patients. Arthritis Care & Research.

Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity.
Lofgren, S., Hinchcliff, M., Carns, M., Wood, T., Aren, K., Arroyo, E., … Khatri, P. (2016). Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity. JCI Insight, 1(21).

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).
Herrick, A. L., Pan, X., Peytrignet, S., Lunt, M., Hesselstrand, R., Mouthon, L., … Denton, C. P. (2017). Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Annals of the Rheumatic Diseases.

Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis
Wu, J. B., Shao, C., Li, X., Li, Q., Hu, P., Shi, C., … Chung, L. W. K. (2014). Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis. JOURNAL OF CLINICAL INVESTIGATION, 124(7), 2891–2908.

Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells
Li, Q., Yin, L., Jones, L. W., Chu, G. C. Y., Wu, J. B. Y., Huang, J.-M., … Zhau, H. E. (2016). Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells. ONCOTARGET, 7(51), 84645–57.

Near-infrared fluorescence imaging of cancer mediated by tumor hypoxia and HIFI alpha/OATPs signaling axis
Wu, J. B., Shao, C., Li, X., Shi, C., Li, Q., Hu, P., … Chung, L. W. K. (2014). Near-infrared fluorescence imaging of cancer mediated by tumor hypoxia and HIFI alpha/OATPs signaling axis. BIOMATERIALS, 35(28), 8175–85.

Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer.
Wu, J., Pan, D., & Chung, L. W. K. (2013). Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer. Translational Andrology and Urology, 2(3), 254–64.

Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients
Liu, S., Tian, Z., Zhang, L., Hou, S., Hu, S., Wu, J., … Shao, C. (2016). Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients. ONCOTARGET, 7(37), 59877–91.

Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations
Li, X., Wu, J. B., Chung, L. W. K., & Huang, W.-C. (2015). Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations. ONCOTARGET, 6(38), 41018–32.

Secondhand Smoke Exposure Enhances Cardiac Fibrosis Effects on the Aging Rat Hearts
Wu, J.-P., Chang-Lee, S. N., Day, C. H., Ho, T.-J., Viswanadha, V. P., Chung, L.-C., … Huang, C.-Y. (2016). Secondhand Smoke Exposure Enhances Cardiac Fibrosis Effects on the Aging Rat Hearts. ACTA CARDIOLOGICA SINICA, 32(5), 594–603.

Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor
Wu, J. B., Shi, C., Chu, G. C.-Y., Xu, Q., Zhang, Y., Li, Q., … Chung, L. W. K. (2015). Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor. BIOMATERIALS, 67, 1–10.

Monoamine Oxidase A Inhibitor-Near-Infrared Dye Conjugate Reduces Prostate Tumor Growth
Wu, J. B., Lin, T.-P., Gallagher, J. D., Kushal, S., Chung, L. W. K., Zhau, H. E., … Shih, J. C. (2015). Monoamine Oxidase A Inhibitor-Near-Infrared Dye Conjugate Reduces Prostate Tumor Growth. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 137(6), 2366–74.

SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer
Li, X., Wu, J. B., Li, Q., Shigemura, K., Chung, L. W. K., & Huang, W.-C. (2016). SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer. ONCOTARGET, 7(11), 12869–84.

Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis
Phung, S., Strange, G., Chung, L. P., Leong, J., Dalton, B., RODDY, J., … Gabbay, E. (2009). Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis. INTERNAL MEDICINE JOURNAL, 39(10), 682–91.

Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1 alpha/OATPs signaling axis
Shi, C., Wu, J. B., Chu, G. C. Y., Li, Q., Wang, R., Zhang, C., … Chung, L. W. K. (2014). Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1 alpha/OATPs signaling axis. ONCOTARGET, 5(20), 10114–26.

beta-Catenin overexpression causes an increase in inflammatory cytokines and NF-kappa B activation in cardiomyocytes
Lin, J. C., Chang, R.-L., Chen, Y.-F., Yang, J.-J., Baskaran, R., Chung, L.-C., … Huang, C.-Y. (2017). beta-Catenin overexpression causes an increase in inflammatory cytokines and NF-kappa B activation in cardiomyocytes. CELLULAR AND MOLECULAR BIOLOGY, 63(1), 17–22.

Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations
Seow, W. J., Matsuo, K., Hsiung, C. A., Shiraishi, K., Song, M., Kim, H. N., … Lan, Q. (2017). Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations. HUMAN MOLECULAR GENETICS, 26(2), 454–65.

Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment
Haddon, D. J., Wand, H. E., Jarrell, J. A., Spiera, R. F., Utz, P. J., Gordon, J. K., & Chung, L. S. (2017). Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment. JOURNAL OF RHEUMATOLOGY, 44(5), 631–38.

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Aggarwal, R., Rider, L. G., Ruperto, N., Bayat, N., Erman, B., Feldman, B. M., … Vencovsky, J. (2017). 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. ARTHRITIS & RHEUMATOLOGY, 69(5), 898–910.

2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Aggarwal, R., Rider, L. G., Ruperto, N., Bayat, N., Erman, B., Feldman, B. M., … Vencovsky, J. (2017). 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. ANNALS OF THE RHEUMATIC DISEASES, 76(5).

Insights into CCL21's roles in immunosurveillance and immunotherapy for gliomas
Nguyen, T., Lagman, C., Chung, L. K., Chen, C. H. J., Poon, J., Ong, V., … Yang, I. (2017). Insights into CCL21's roles in immunosurveillance and immunotherapy for gliomas. JOURNAL OF NEUROIMMUNOLOGY, 305, 29–34.

EXTRACELLULAR-MATRIX AND ANDROGEN RECEPTOR EXPRESSION ASSOCIATED WITH SPONTANEOUS TRANSFORMATION OF RAT PROSTATE FIBROBLASTS
Freeman, M. R., Song, Y., Carson, D. D., Guthrie, P. D., & Chung, L. W. K. (1991). EXTRACELLULAR-MATRIX AND ANDROGEN RECEPTOR EXPRESSION ASSOCIATED WITH SPONTANEOUS TRANSFORMATION OF RAT PROSTATE FIBROBLASTS. CANCER RESEARCH, 51(7), 1910–16.

Pregnancy outcomes in adult patients with dermatomyositis and polymyositis.
Kolstad, K. D., Fiorentino, D., Li, S., Chakravarty, E. F., & Chung, L. (2017). Pregnancy outcomes in adult patients with dermatomyositis and polymyositis. Seminars in Arthritis and Rheumatism.

A multi-center crossover study of MQX-503, a topical formulation of nitroglycerin, in patients with Raynaud's phenomenon
Denton, C. P., Fiorentino, D., Herrick, A., Sule, S., Rothfield, N., Belch, J., … Wigley, F. M. (2007). A multi-center crossover study of MQX-503, a topical formulation of nitroglycerin, in patients with Raynaud's phenomenon. ARTHRITIS AND RHEUMATISM, 56(12), 4238.

Validation Of The ICD-CM-9 Code For Systemic Sclerosis Using Updated ACR/EULAR Classification Criteria
Yaqub, A., Chung, L., Fiorentino, D., & Krishnan, E. (2013). Validation Of The ICD-CM-9 Code For Systemic Sclerosis Using Updated ACR/EULAR Classification Criteria. ARTHRITIS AND RHEUMATISM, 65, S772–S773.

Dermatomyositis Associated with Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: A Longitudinal Analysis
Lewis, M., Li, S., Chung, L., & Fiorentino, D. (2015). Dermatomyositis Associated with Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: A Longitudinal Analysis. ARTHRITIS & RHEUMATOLOGY, 67.

Muscle Disease in Systemic Sclerosis Is Associated with an Increased Risk for Cardiac Involvement
Hong, J., Valenzuela, A., Fiorentino, D., & Chung, L. (2014). Muscle Disease in Systemic Sclerosis Is Associated with an Increased Risk for Cardiac Involvement. ARTHRITIS & RHEUMATOLOGY, 66, S314–S315.

Effect of the ETA Selective Endothelin Receptor Antagonist Ambrisentan on Digital Ulcers in Patients with Systemic Sclerosis: Results of a Prospective Pilot Study.
Chung, L., Arefiev, K., Yaqub, A., Strahs, D., Lingala, B., & Fiorentino, D. (2011). Effect of the ETA Selective Endothelin Receptor Antagonist Ambrisentan on Digital Ulcers in Patients with Systemic Sclerosis: Results of a Prospective Pilot Study. ARTHRITIS AND RHEUMATISM, 63(10), S259–S260.

Identification Of Clinical Features and Risk Factors Associated With Calcinosis In Adult Patients With Dermatomyositis
Valenzuela, A., Chung, L., Casciola-Rosen, L., Rosen, A., & Fiorentino, D. (2013). Identification Of Clinical Features and Risk Factors Associated With Calcinosis In Adult Patients With Dermatomyositis. ARTHRITIS AND RHEUMATISM, 65, S889.

Antibodies to NXP-2 and Transcriptional Intermediary Factor-Gamma Identify Patients with Cancer-Associated Dermatomyositis.
Fiorentino, D., Christopher-Stine, L., Chung, L., Lingala, B., Mammen, A. L., Rosen, A., & Casciola-Rosen, L. (2012). Antibodies to NXP-2 and Transcriptional Intermediary Factor-Gamma Identify Patients with Cancer-Associated Dermatomyositis. ARTHRITIS AND RHEUMATISM, 64(10), S828.

Comparison of responders and non-responders to MQX-503, a novel investigational topical nitroglycerin formulation, in treatment of scieroderma-related and non-scleroderma-related Raynaud'S phenomenon
Herrick, A., Denton, C., Fiorentino, D., Sule, S., Rothfield, N., Belch, J., … Gregory, J. (2008). Comparison of responders and non-responders to MQX-503, a novel investigational topical nitroglycerin formulation, in treatment of scieroderma-related and non-scleroderma-related Raynaud'S phenomenon. ARTHRITIS AND RHEUMATISM, 58(9), S822.

Immunosignature Technology Differentiates Patients with Systemic Sclerosis and Internal Organ Involvement
Chung, L., Fiorentino, D., Gerwien, R., Jia, K., Legutki, J. B., Vergara, A. V., … Sykes, K. (2016). Immunosignature Technology Differentiates Patients with Systemic Sclerosis and Internal Organ Involvement. ARTHRITIS & RHEUMATOLOGY. WILEY.

Cutaneous Ulceration in Dermatomyositis: Association with MDA-5 and Interstitial Lung Disease.
Narang, N., Casciola-Rosen, L., Rosen, A., Fiorentino, D., & Chung, L. (2012). Cutaneous Ulceration in Dermatomyositis: Association with MDA-5 and Interstitial Lung Disease. ARTHRITIS AND RHEUMATISM, 64(10), S326.

A pilot trial of treprostinil (Remodulin (R)) for the treatment and prevention of digital ischemic lesions in patients with systemic sclerosis.
Chung, L., & Fiorentino, D. (2004). A pilot trial of treprostinil (Remodulin (R)) for the treatment and prevention of digital ischemic lesions in patients with systemic sclerosis. ARTHRITIS AND RHEUMATISM, 50(12), 4086.

Validation Of The Cutaneous Dermatomyositis Disease Area and Severity Index: Characterizing Severity and Assessing Responsiveness To Clinical Change
Anyanwu, C. O., Fiorentino, D., Chung, L., Wang, Y., Propert, K. J., & Werth, V. P. (2013). Validation Of The Cutaneous Dermatomyositis Disease Area and Severity Index: Characterizing Severity and Assessing Responsiveness To Clinical Change. ARTHRITIS AND RHEUMATISM, 65, S824.

Evidence supports blind screening for internal malignancy in dermatomyositis Data from 2 large US dermatology cohorts
Leatham, H., Schadt, C., Chisolm, S., Fretwell, D., Chung, L., Callen, J. P., & Fiorentino, D. (2018). Evidence supports blind screening for internal malignancy in dermatomyositis Data from 2 large US dermatology cohorts. MEDICINE, 97(2), e9639.

Pregnancy Outcomes In Adult Patients With Dermatomyositis and Polymyositis
Chung, L., Fiorentino, D., Li, S., & Chakravarty, E. (2013). Pregnancy Outcomes In Adult Patients With Dermatomyositis and Polymyositis. ARTHRITIS AND RHEUMATISM, 65, S886–S887.

International Classification of Diseases-Clinical Modification-9 Codes for the Diagnosis of Dermatomyositis and Polymyositis in Discharge Summaries: Evidence of Acceptable Validity
Narang, N., Fiorentino, D., Krishnan, E., & Chung, L. (2011). International Classification of Diseases-Clinical Modification-9 Codes for the Diagnosis of Dermatomyositis and Polymyositis in Discharge Summaries: Evidence of Acceptable Validity. ARTHRITIS AND RHEUMATISM, 63(10), S90.

Multi-Organ RNA-Sequencing of Systemic Sclerosis (SSc) Patients Shows Reproducible Gene Expression Profiles Across Organ Systems
Mehta, B. K., Johnson, M. E., Archambault, K. A., Wood, T. A., Valenzuela, A., Crawford, A., … Whitfield, M. (2016). Multi-Organ RNA-Sequencing of Systemic Sclerosis (SSc) Patients Shows Reproducible Gene Expression Profiles Across Organ Systems. ARTHRITIS & RHEUMATOLOGY. WILEY.

Calcinosis Is Associated with Digital Ulcers and Osteoporosis in Patients with Systemic Sclerosis
Valenzuela, A., Baron, M., Herrick, A. L., Proudman, S., Stevens, W., Sofia Rodriguez-Reyna, T., … Chung, L. (2015). Calcinosis Is Associated with Digital Ulcers and Osteoporosis in Patients with Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 67.

Validation Of a Novel Radiographic Scoring System For Calcinosis Affecting The Hands Of Patients With Systemic Sclerosis.
Chung, L., Vergara, A. M. V., Fiorentino, D., Stevens, K., Li, S., Harris, J., … Baron, M. (2013). Validation Of a Novel Radiographic Scoring System For Calcinosis Affecting The Hands Of Patients With Systemic Sclerosis. ARTHRITIS AND RHEUMATISM, 65, S289–S290.

Rituximab in the treatment of patients with dermatomyositis: 12 week interim analysis of a pilot trial.
Chung, L., Genovese, M. C., & Fiorentino, D. (2005). Rituximab in the treatment of patients with dermatomyositis: 12 week interim analysis of a pilot trial. ARTHRITIS AND RHEUMATISM, 52(12), 4088.

2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects
Rider, L. G., Ruperto, N., Pistorio, A., Erman, B., Bayat, N., Lachenbruch, P. A., … Aggarwal, R. (2017). 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects. RHEUMATOLOGY, 56(11), 1884–93.

Multi-Organ RNA-Sequencing of Patients with Systemic Sclerosis (SSc) Finds That Intrinsic Subsets Are Conserved across Organ Systems
Mehta, B. K., Franks, J., Cai, G., Toledo, D., Wood, T. A., Archambault, K. A., … Whitfield, M. L. (2017). Multi-Organ RNA-Sequencing of Patients with Systemic Sclerosis (SSc) Finds That Intrinsic Subsets Are Conserved across Organ Systems. ARTHRITIS & RHEUMATOLOGY. WILEY.

Factors Associated With Clinical Remission of Skin Disease in Dermatomyositis
Wolstencroft, P. W., Chung, L., Li, S., Casciola-Rosen, L., & Fiorentino, D. F. (2018). Factors Associated With Clinical Remission of Skin Disease in Dermatomyositis. JAMA DERMATOLOGY, 154(1), 44–51.

Comprehensive Characterization of Calcinosis in a Multicenter International Cohort of Patients with Systemic Sclerosis
Valenzuela, A., Gordon, J. K., Sofia Rodriguez-Reyna, T., Proudman, S., Baron, M., Hinchcliff, M., … Chung, L. (2016). Comprehensive Characterization of Calcinosis in a Multicenter International Cohort of Patients with Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 68.

Activity of Type I and Type II Interferons in Dermatomyositis Skin Is Correlated with Characteristic Pathologic Features
Leatham, H. W., Rieger, K., Chung, L., Li, S., Higgs, B. W., Yao, Y., … Fiorentino, D. (2015). Activity of Type I and Type II Interferons in Dermatomyositis Skin Is Correlated with Characteristic Pathologic Features. ARTHRITIS & RHEUMATOLOGY, 67.

MQX-503, a novel topical nitroglycerin formulation, improves severity of symptoms associated with Raynaud's phenomenon
Belch, J., Fiorentino, D., Denton, C., Herrick, A., Sule, S., Steen, V., … Gregory, J. K. (2008). MQX-503, a novel topical nitroglycerin formulation, improves severity of symptoms associated with Raynaud's phenomenon. ARTHRITIS AND RHEUMATISM, 58(9), S622.

Use of imatinib to treat systemic sclerosis: A prospective case series
Arefiev, K., Fiorentino, D., Chung, L., & Robinson, W. (2009). Use of imatinib to treat systemic sclerosis: A prospective case series. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 60(3), AB3.

Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenon
Rothfield, N., Shapiro, L., Fiorentino, D., Chung, L., Denton, C., Herrick, A., … Wigey, F. M. (2008). Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenon. ARTHRITIS AND RHEUMATISM, 58(9), S821.

Excess Mortality From Atherosclerotic Cardiovascular Disease in Systemic Sclerosis Compared to Lupus and Rheumatoid Arthritis
Dave, A. J., Lingala, B., Fiorentino, D., Krishnan, E., & Chung, L. (2012). Excess Mortality From Atherosclerotic Cardiovascular Disease in Systemic Sclerosis Compared to Lupus and Rheumatoid Arthritis. ARTHRITIS AND RHEUMATISM, 64(10), S302–S303.

Transcriptome Sequencing Reveals Genetic Polymorphisms Associated with Ssc Gene Expression Subtypes
Cai, G., Mehta, B. K., Huang, M., Franks, J., Wood, T. A., Kolstad, K. D., … Whitfield, M. L. (2017). Transcriptome Sequencing Reveals Genetic Polymorphisms Associated with Ssc Gene Expression Subtypes. ARTHRITIS & RHEUMATOLOGY, 69.

Characterization of patients with clinical overlap of morphea and systemic sclerosis: A case series
Chen, J. K., Chung, L., & Fiorentino, D. F. (2016). Characterization of patients with clinical overlap of morphea and systemic sclerosis: A case series. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(6), 1272–74.

Factors Associated with Clinical Remission of Skin Disease in Dermatomyositis
Wolstencroft, P., Chung, L., Li, S., Casciola-Rosen, L., & Fiorentino, D. (2017). Factors Associated with Clinical Remission of Skin Disease in Dermatomyositis. ARTHRITIS & RHEUMATOLOGY, 69.

Preterm Birth Phenotypes in Women with Autoimmune Diseases
Kolstad, K. D., Mayo, J. A., Chung, L., Chaichian, Y., Kelly, V. M., Druzin, M., … Simard, J. F. (2017). Preterm Birth Phenotypes in Women with Autoimmune Diseases. ARTHRITIS & RHEUMATOLOGY, 69.

Identification of Biomarkers Predictive of Pulmonary Arterial Hypertension in Systemic Sclerosis
Kolstad, K. D., Holmes, T., Rosenberg-Hasson, Y., Sweatt, A., Zamanian, R. T., Li, S., … Chung, L. (2017). Identification of Biomarkers Predictive of Pulmonary Arterial Hypertension in Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 69.

Luminex and Autoantigen Microarray Analysis of Sera from Patients with Diffuse Cutaneous Systemic Sclerosis Reveals Changes Associated with Imatinib Mesylate Treatment.
Haddon, D. J., Wand, H., Utz, P. J., Spiera, R. F., Gordon, J. K., & Chung, L. (2014). Luminex and Autoantigen Microarray Analysis of Sera from Patients with Diffuse Cutaneous Systemic Sclerosis Reveals Changes Associated with Imatinib Mesylate Treatment. ARTHRITIS & RHEUMATOLOGY, 66, S388.

Long-term Outcomes in Systemic Sclerosis Associated Pulmonary Arterial Hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS).
Kolstad, K. D., Li, S., Steen, V., & Chung, L. (2018). Long-term Outcomes in Systemic Sclerosis Associated Pulmonary Arterial Hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS). Chest.

Predictors of Long-Term Outcomes in Systemic Sclerosis Associated Pulmonary Arterial Hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry
Kolstad, K., Li, S., Steen, V. D., & Chung, L. (2016). Predictors of Long-Term Outcomes in Systemic Sclerosis Associated Pulmonary Arterial Hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry. ARTHRITIS & RHEUMATOLOGY, 68.

Transforming Growth Factor Beta 3 (TGFB3) - a Novel Systemic Sclerosis Susceptibility Locus Involved in Fibrosis and Th17 Cell Development Identified By Genome-Wide Association Study in African Americans from the Genome Research in African American Scleroderma Patients Consortium
Gourh, P., Remmers, E. F., Satpathy, A., Boyden, S., Morgan, N. D., Shah, A. A., … Kastner, D. L. (2017). Transforming Growth Factor Beta 3 (TGFB3) - a Novel Systemic Sclerosis Susceptibility Locus Involved in Fibrosis and Th17 Cell Development Identified By Genome-Wide Association Study in African Americans from the Genome Research in African American Scleroderma Patients Consortium. ARTHRITIS & RHEUMATOLOGY. WILEY.

Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry
Chung, L., Fairchild, R. M., Furst, D. E., Li, S., Alkassab, F., Bolster, M. B., … Zamanian, R. T. (2017). Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 35(4), S106–S113.

Clinical and Serological Features of Systemic Sclerosis in a Multicenter African American Cohort: Analysis of the Genome Research in African American Scleroderma Patients Clinical Database
Morgan, N. D., Shah, A. A., Mayes, M. D., Domsic, R. T., Medsger, T. A., Steen, V. D., … Boin, F. (2017). Clinical and Serological Features of Systemic Sclerosis in a Multicenter African American Cohort: Analysis of the Genome Research in African American Scleroderma Patients Clinical Database. ARTHRITIS & RHEUMATOLOGY, 69.

A Phase 2 Study of Safety and Efficacy of Anabasum (JBT-101), a Cannabinoid Receptor Type 2 Agonist, in Diffuse Cutaneous Systemic Sclerosis
Spiera, R. F., Hummers, L. K., Chung, L., Frech, T. M., Domsic, R. T., Hsu, V., … White, B. (2017). A Phase 2 Study of Safety and Efficacy of Anabasum (JBT-101), a Cannabinoid Receptor Type 2 Agonist, in Diffuse Cutaneous Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 69.

Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database
Morgan, N. D., Shah, A. A., Mayes, M. D., Domsic, R. T., Medsger, T. A., Steen, V. D., … Boin, F. (2017). Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database. MEDICINE, 96(51), e8980.

Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
Herrick, A. L., Peytrignet, S., Lunt, M., Pan, X., Hesselstrand, R., Mouthon, L., … Denton, C. P. (2018). Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. ANNALS OF THE RHEUMATIC DISEASES, 77(4), 563–70.

Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study
Peytrignet, S., Denton, C. P., Lunt, M., Hesselstrand, R., Mouthon, L., Silman, A., … Herrick, A. L. (2018). Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. RHEUMATOLOGY, 57(2), 370–81.

HLA Type Imputation in the Genome Research in African American Scleroderma Patients (GRASP) Cohort Reveals Strong Associations of African Ancestry MHC Class II Types with Scleroderma and Lack of Class I HLA Type Associations
Remmers, E. F., Gourh, P., Boyden, S., Morgan, N. D., Shah, A. A., Adeyemo, A., … Kastner, D. L. (2017). HLA Type Imputation in the Genome Research in African American Scleroderma Patients (GRASP) Cohort Reveals Strong Associations of African Ancestry MHC Class II Types with Scleroderma and Lack of Class I HLA Type Associations. ARTHRITIS & RHEUMATOLOGY, 69.

Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis
Arnold, M. B., Khanna, D., Denton, C. P., van Laar, J. M., Frech, T. M., Anderson, M. E., … Pope, J. E. (2018). Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis. RHEUMATOLOGY, 57(1), 152–57.

Safety and Efficacy of Anabasum (JBT-101) in Diffuse Cutaneous Systemic Sclerosis (dcSSc) Subjects Treated in an Open-Label Extension of Trial JBT101-SSc-001
Spiera, R. F., Hummers, L. K., Chung, L., Frech, T. M., Domsic, R. T., Hsu, V., … White, B. (2017). Safety and Efficacy of Anabasum (JBT-101) in Diffuse Cutaneous Systemic Sclerosis (dcSSc) Subjects Treated in an Open-Label Extension of Trial JBT101-SSc-001. ARTHRITIS & RHEUMATOLOGY, 69.

Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
Khanna, D., Denton, C. P., Lin, C. J. F., van Laar, J. M., Frech, T. M., Anderson, M. E., … Furst, D. E. (2018). Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate). ANNALS OF THE RHEUMATIC DISEASES, 77(2), 212–20.

An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature
Sundaram, S. M., & Chung, L. (2018). An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature. CURRENT RHEUMATOLOGY REPORTS, 20(2), 10.

EXPRESS: Non-invasive Right Ventricular Load Adaptability Indices in Patients with Scleroderma-Associated Pulmonary Arterial Hypertension.
French, S., Amsallem, M., Ouazani, N., Li, S., Kudelko, K., Zamanian, R., … Chung, L. (2018). EXPRESS: Non-invasive Right Ventricular Load Adaptability Indices in Patients with Scleroderma-Associated Pulmonary Arterial Hypertension. Pulmonary Circulation, 2045894018788268.

A clinical comparison of systemic sclerosis-versus systemic lupus erythematosus-pulmonary arterial hypertension using the REVEAL registry
Chung, L., Liu, J., Parsons, L., McGoon, M., Badesch, D., Nicholls, M., & Zamanian, R. (2008). A clinical comparison of systemic sclerosis-versus systemic lupus erythematosus-pulmonary arterial hypertension using the REVEAL registry. ARTHRITIS AND RHEUMATISM, 58(9), S948.

Dermatomyositis and Pregnancy: Assessment of Disease Activity and Pregnancy Outcomes Complicated By Maternal Dermatomyositis
Miller, G., Moore, E., Valenzuela, A., Chung, L., & Werth, V. P. (2016). Dermatomyositis and Pregnancy: Assessment of Disease Activity and Pregnancy Outcomes Complicated By Maternal Dermatomyositis. ARTHRITIS & RHEUMATOLOGY, 68.

Recommendations For Screening and Detection Of Connective-Tissue Disease Associated Pulmonary Arterial Hypertension
Khanna, D., Gladue, H., Fitzgerald, J. D., Channick, R. N., Chung, L., Distler, O., … McLaughlin, V. (2013). Recommendations For Screening and Detection Of Connective-Tissue Disease Associated Pulmonary Arterial Hypertension. ARTHRITIS AND RHEUMATISM, 65, S1100–S1101.

"PHAROS" pulmonary hypertension (PH) assessment and recognition of outcomes in systemic sclerosis (SSc): Pre-pulmonary arterial hypertension (PAH) preliminary outcomes
Fischer, A., Impens, A., Hsu, V., Shapiro, L., Mayes, M., Hummers, L., … Steen, V. (2008). "PHAROS" pulmonary hypertension (PH) assessment and recognition of outcomes in systemic sclerosis (SSc): Pre-pulmonary arterial hypertension (PAH) preliminary outcomes. ARTHRITIS AND RHEUMATISM, 58(9), S377.

Patient Centered Approach to Disease Modification in Scleroderma: Results from the faSScinate Trial of Tocilizumab Compared to Placebo in Active Diffuse Cutaneous Systemic Sclerosis
Arnold, M., Khanna, D., Denton, C., Lin, C., van Laar, J., Frech, T., … Pope, J. (2017). Patient Centered Approach to Disease Modification in Scleroderma: Results from the faSScinate Trial of Tocilizumab Compared to Placebo in Active Diffuse Cutaneous Systemic Sclerosis. JOURNAL OF RHEUMATOLOGY, 44(6), 881.

Lower Socioeconomic Status, Male Gender and Diffuse Scleroderma Are Associated with Worse Survival in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Cohort
Gordon, J. K., Zhang, W., Chung, L., Ma, Y., & Steen, V. D. (2014). Lower Socioeconomic Status, Male Gender and Diffuse Scleroderma Are Associated with Worse Survival in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Cohort. ARTHRITIS & RHEUMATOLOGY, 66, S321–S322.

Dyspnea in pcleroderma patients from the PHAROS Registry: a major contributor to disability
Chung, L., Chen, H., & Steen, V. (2010). Dyspnea in pcleroderma patients from the PHAROS Registry: a major contributor to disability. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 28(5), S62.

Digital Ischemic Ulcers in Scleroderma Treated with Oral Treprostinil Diethanolamine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Seibold, J. R., Wigley, F. M., Schiopu, E., Denton, C. D., Silver, R. M., Steen, V. D., … Wade, M. (2011). Digital Ischemic Ulcers in Scleroderma Treated with Oral Treprostinil Diethanolamine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study. ARTHRITIS AND RHEUMATISM. WILEY-BLACKWELL.

Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis Interstitial Lung Disease
Khanna, D., Albera, C., Fischer, A., Seibold, J. R., Khalidi, N. A., Raghu, G., … Gorina, E. (2015). Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis Interstitial Lung Disease. ARTHRITIS & RHEUMATOLOGY, 67.

Differential Expression of Hepatocyte Growth Factor (HGF) in Patients with Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Chung, L., Cramb, C., Robinson, W. H., Steen, V. D., & Zamanian, R. T. (2012). Differential Expression of Hepatocyte Growth Factor (HGF) in Patients with Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. ARTHRITIS AND RHEUMATISM, 64(10), S632.

There Is a Need for New Systemic Sclerosis Subset Criteria: A Content Analytic Approach
Johnson, S., Soowamber, M., Fransen, J., Khanna, D., van den Hoogen, F. H. J., Baron, M., … Pope, J. E. (2015). There Is a Need for New Systemic Sclerosis Subset Criteria: A Content Analytic Approach. ARTHRITIS & RHEUMATOLOGY, 67.

Pulmonary Hypertension and Interstitial Lung Disease within Pharos: Impact of Extent of Fibrosis and Pulmonary Physiology On Cardiac Hemodynamic Parameters
Fischer, A., Mathai, S. C., Bolster, M. B., Chung, L., Csuka, M. E., Domsic, R. T., … Steen, V. D. (2012). Pulmonary Hypertension and Interstitial Lung Disease within Pharos: Impact of Extent of Fibrosis and Pulmonary Physiology On Cardiac Hemodynamic Parameters. ARTHRITIS AND RHEUMATISM, 64(10), S628.

Connective tissue disease-associated pulmonary arterial hypertension: "Beijing style"
Chung, L., & Kawut, S. M. (2014). Connective tissue disease-associated pulmonary arterial hypertension: "Beijing style". EUROPEAN RESPIRATORY JOURNAL, 44(4), 839–41.

Evolving Concepts of Diagnosis and Classification
Chung, L., Fransen, J., & Van den Hoogen, F. H. J. (2012). Evolving Concepts of Diagnosis and Classification. SCLERODERMA: FROM PATHOGENESIS TO COMPREHENSIVE MANAGEMENT, 53–69.

Right Ventricular Load-Adaptability and Response to Therapy in Scleroderma Versus Idiopathic Pulmonary Arterial Hypertension
French, S., Ouazani, N., Amsallem, M., Li, S., Zamanian, R. T., Chung, L., & Haddad, F. (2016). Right Ventricular Load-Adaptability and Response to Therapy in Scleroderma Versus Idiopathic Pulmonary Arterial Hypertension. ARTHRITIS & RHEUMATOLOGY, 68.

Functional Class Change in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Associations with Survival and Exercise Capacity
Chung, L., Parsons, L. S., Hassoun, P. M., McGoon, M. D., Badesch, D. B., Miller, D. P., … Zamanian, R. T. (2011). Functional Class Change in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Associations with Survival and Exercise Capacity. ARTHRITIS AND RHEUMATISM, 63(10), S575.

Differential expression of hepatocyte growth factor in patients with systemic sclerosis-associated pulmonary arterial hypertension
Sung, Y. K., Zamanian, R. T., Wagner, C. A., Robinson, W., Steen, V., & Chung, L. (2017). Differential expression of hepatocyte growth factor in patients with systemic sclerosis-associated pulmonary arterial hypertension. JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2(3), 225–30.

Survival, Hospitalization or Need for Combination Therapy At One Year in Patients with Scleroderma-Associated Pulmonary Arterial Hypertension
Domsic, R. T., Chung, L., Gordon, J. K., Cloonan, Y., & Steen, V. D. (2012). Survival, Hospitalization or Need for Combination Therapy At One Year in Patients with Scleroderma-Associated Pulmonary Arterial Hypertension. ARTHRITIS AND RHEUMATISM, 64(10), S310–S311.

Pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS): Patients with pulmonary hypertension
Hinchcliff, M. E., Hsu, V., Bolster, M., Hummers, L., Seibold, J., Csuka, M. E., … Steen, V. (2008). Pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS): Patients with pulmonary hypertension. ARTHRITIS AND RHEUMATISM, 58(9), S948.

Survival in Systemic Sclerosis-Pulmonary Arterial Hypertension By Serum Autoantibody Status
Hinchcliff, M., Khanna, S., Lee, J., Almagor, O., Chang, R. W., Steen, V. D., & Chung, L. (2014). Survival in Systemic Sclerosis-Pulmonary Arterial Hypertension By Serum Autoantibody Status. ARTHRITIS & RHEUMATOLOGY, 66, S1180.

Intestinal Pseudo-Obstruction in Patients with Systemic Sclerosis: An Analysis of the Nationwide Inpatient Sample.
Valenzuela, A., Li, S., Becker, L., Fernandez-Becker, N., Khanna, D., Linda Nguyen, & Chung, L. (2014). Intestinal Pseudo-Obstruction in Patients with Systemic Sclerosis: An Analysis of the Nationwide Inpatient Sample. ARTHRITIS & RHEUMATOLOGY, 66, S1310.

World Health Organization Classification of Pulmonary Hypertension and Survival in Systemic Sclerosis Patients in the Pharos Cohort
Gordon, J. K., Chung, L., Domsic, R. T., Huang, W.-T., Lyman, S. L., Horn, E. M., & Steen, V. D. (2012). World Health Organization Classification of Pulmonary Hypertension and Survival in Systemic Sclerosis Patients in the Pharos Cohort. ARTHRITIS AND RHEUMATISM, 64(10), S629.

Better Survival in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Patients Enrolled in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry
Chung, L., Domsic, R. T., Lingala, B., & Steen, V. D. (2011). Better Survival in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Patients Enrolled in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry. ARTHRITIS AND RHEUMATISM, 63(10), S673.

Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis
Tartar, D. M., Chung, L., & Fiorentino, D. F. (2018). Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis. CLINICS IN DERMATOLOGY, 36(4), 508–24.

Calcinosis in scleroderma.
Valenzuela, A., Song, P., & Chung, L. (2018). Calcinosis in scleroderma. Current Opinion in Rheumatology.

The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts
Dougherty, D. H., Kwakkenbos, L., Carrier, M.-E., Salazar, G., Assassi, S., Baron, M., … Mayes, M. D. (2018). The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts. RHEUMATOLOGY, 57(9), 1623–31.

Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry.
Hsu, V. M., Chung, L., Hummers, L. K., Shah, A., Simms, R., Bolster, M., … Steen, V. D. (2018). Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry. The Journal of Rheumatology.

Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans
Gourh, P., Remmers, E. F., Boyden, S. E., Alexander, T., Morgan, N. D., Shah, A. A., … Wigley, F. M. (2018). Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans. ARTHRITIS & RHEUMATOLOGY, 70(10), 1654–60.

Multi-Organ RNA-Sequencing of Patients with Systemic Sclerosis (SSc) Finds That Intrinsic Subsets Are Conserved across Organ Systems
Mehta, B. K., Franks, J., Wang, Y., Cai, G., Toledo, D. M., Wood, T. A., … Whitfield, M. L. (2018). Multi-Organ RNA-Sequencing of Patients with Systemic Sclerosis (SSc) Finds That Intrinsic Subsets Are Conserved across Organ Systems. ARTHRITIS & RHEUMATOLOGY. WILEY.

Identification of Risk Factors for Gastric Antral Vascular Ectasia (GAVE) Among Systemic Sclerosis Patients
Serling-Boyd, N., Li, S., Fiorentino, D., Becker, L., Fernandez-Becker, N., Clarke, J., & Chung, L. (2018). Identification of Risk Factors for Gastric Antral Vascular Ectasia (GAVE) Among Systemic Sclerosis Patients. ARTHRITIS & RHEUMATOLOGY, 70.

Increased Mortality in Black and Asian Patients with Systemic Sclerosis in Northern California
Chung, M., Dontsi, M., Postlethwaite, D., Kesh, S., Zaba, L., & Chung, L. (2018). Increased Mortality in Black and Asian Patients with Systemic Sclerosis in Northern California. ARTHRITIS & RHEUMATOLOGY, 70.

Rituximab Versus Mycophenolate Mofetil in Interstitial Lung Disease Secondary to Connective Tissue Disease
Zhu, L., Li, S., Gagne, L., Jacobs, S., Morisset, J., Mooney, J., … Chung, L. (2018). Rituximab Versus Mycophenolate Mofetil in Interstitial Lung Disease Secondary to Connective Tissue Disease. ARTHRITIS & RHEUMATOLOGY, 70.

Safety and Efficacy of Lenabasum in an Open-Label Extension of a Phase 2 Study in Diffuse Cutaneous Systemic Sclerosis Subjects
Spiera, R. F., Hummers, L. K., Chung, L., Frech, T. M., Domsic, R. T., Hsu, V., … White, B. (2018). Safety and Efficacy of Lenabasum in an Open-Label Extension of a Phase 2 Study in Diffuse Cutaneous Systemic Sclerosis Subjects. ARTHRITIS & RHEUMATOLOGY, 70.

HLA Contributions to Risk and Protection for Anti-Centromere Autoantibody-Positive Scleroderma
Remmers, E. F., Alexander, T., Morgan, N. D., Shah, A. A., Mayes, M. D., Adeyemo, A., … Gourh, P. (2018). HLA Contributions to Risk and Protection for Anti-Centromere Autoantibody-Positive Scleroderma. ARTHRITIS & RHEUMATOLOGY, 70.

Abatacept Vs. Placebo in Early Diffuse Cutaneous Systemic Sclerosis-Results of a Phase 2 Investigator Initiated, Double- Blind, Placebo-Controlled, Multicenter, Randomized Controlled Trial Study
Khanna, D., Spino, C., Bush, E., Johnson, S., Chung, L., Molitor, J., … Furst, D. E. (2018). Abatacept Vs. Placebo in Early Diffuse Cutaneous Systemic Sclerosis-Results of a Phase 2 Investigator Initiated, Double- Blind, Placebo-Controlled, Multicenter, Randomized Controlled Trial Study. ARTHRITIS & RHEUMATOLOGY. WILEY.

Strong HLA and Novel Non-HLA Associations Identified By Auto-Antibody Subset Analysis of African Americans with Scleroderma from the Genome Research in African American Scleroderma Patients Cohort
Gourh, P., Remmers, E. F., Alexander, T., Boyden, S., Morgan, N. D., Shah, A. A., … Kastner, D. L. (2018). Strong HLA and Novel Non-HLA Associations Identified By Auto-Antibody Subset Analysis of African Americans with Scleroderma from the Genome Research in African American Scleroderma Patients Cohort. ARTHRITIS & RHEUMATOLOGY, 70.

An interim report of the Scleroderma Clinical Trials Consortium working groups
Baron, M., Kahaleh, B., Bernstein, E. J., Chung, L., Clements, P. J., Denton, C., … Vacca, A. (2019). An interim report of the Scleroderma Clinical Trials Consortium working groups. JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 4(1), 17–27.

Upper Extremity Angiographic Patterns in Systemic Sclerosis: Implications for Surgical Treatment.
Leyden, J., Burn, M. B., Wong, V., Leon, D. S., Kaizawa, Y., Chung, L., & Chang, J. (2019). Upper Extremity Angiographic Patterns in Systemic Sclerosis: Implications for Surgical Treatment. The Journal of Hand Surgery.

Change in diffusing capacity for carbon monoxide as a predictor of outcomes in connective tissue disease-associated pulmonary arterial hypertension: Analysis from the REVEAL registry
Zamanian, R., Kudelko, K., Miller, D., McGoon, M., Benza, R., Hassoun, P., … Chung, L. (2012). Change in diffusing capacity for carbon monoxide as a predictor of outcomes in connective tissue disease-associated pulmonary arterial hypertension: Analysis from the REVEAL registry. EUROPEAN RESPIRATORY JOURNAL. EUROPEAN RESPIRATORY SOC JOURNALS LTD.

Characterizing systemic sclerosis in an ethnically diverse population
Schmajuk, G., Bush, T. M., Burkham, J., & Chung, L. (2007). Characterizing systemic sclerosis in an ethnically diverse population. ARTHRITIS AND RHEUMATISM, 56(12), 4302.

Hospitalizations and in-hospital mortality in patients with systemic sclerosis in the United States.
Chung, L., Krishnan, E., Friedman, G. D., & Chakravarty, E. F. (2006). Hospitalizations and in-hospital mortality in patients with systemic sclerosis in the United States. ARTHRITIS AND RHEUMATISM, 54(12), 4075–76.

Myopathy associated with SSc a joint EUSTAR-SCTC sub-cohort initiative
Maurer, B., Jaeger, V., Chung, L., Hsu, V., Walker, U., & Distler, O. (2015). Myopathy associated with SSc a joint EUSTAR-SCTC sub-cohort initiative. SWISS MEDICAL WEEKLY, 145, 8S.

Safety and tolerability of pirfenidone (PFD) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)-The LOTUSS study
Khanna, D., Albera, C., Fischer, A., Seibold, J., Raghu, G., Khalidi, N., … Gorina, E. (2015). Safety and tolerability of pirfenidone (PFD) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)-The LOTUSS study. EUROPEAN RESPIRATORY JOURNAL, 46.

An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups.
Baron, M., Kahaleh, B., Bernstein, E. J., Chung, L., Clements, P. J., Denton, C., … Vacca, A. (2019). An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups. Journal of Scleroderma and Related Disorders, 4(1), 17–27.

Developing classification criteria for skin-predominant dermatomyositis: the Delphi process.
Concha, J. S., Pena, S., Gaffney, R. G., Patel, B., Tarazi, M., Kushner, C. J., … Werth, V. P. (2019). Developing classification criteria for skin-predominant dermatomyositis: the Delphi process. The British Journal of Dermatology.

Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry
Hsu, V. M., Chung, L., Hummers, L. K., Shah, A., Simms, R., Bolster, M., … Steen, V. D. (2019). Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry. JOURNAL OF RHEUMATOLOGY, 46(2), 176–83.

Calcinosis in scleroderma
Valenzuela, A., Song, P., & Chung, L. (2018). Calcinosis in scleroderma. CURRENT OPINION IN RHEUMATOLOGY, 30(6), 554–61.

Non-invasive right ventricular load adaptability indices in patients with scleroderma-associated pulmonary arterial hypertension
French, S., Amsallem, M., Ouazani, N., Li, S., Kudelko, K., Zamanian, R. T., … Chung, L. (2018). Non-invasive right ventricular load adaptability indices in patients with scleroderma-associated pulmonary arterial hypertension. PULMONARY CIRCULATION, 8(3).

Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS)
Kolstad, K. D., Li, S., Steen, V., & Chung, L. (2018). Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS). CHEST, 154(4), 862–71.

Pregnancy outcomes in adult patients with dermatomyositis and polymyositis
Kolstad, K. D., Fiorentino, D., Li, S., Chakravarty, E. F., & Chung, L. (2018). Pregnancy outcomes in adult patients with dermatomyositis and polymyositis. SEMINARS IN ARTHRITIS AND RHEUMATISM, 47(6), 865–69.

Systemic Sclerosis 2011
Chung, L., Distler, O., Hummers, L., Krishnan, E., & Steen, V. (2011). Systemic Sclerosis 2011. INTERNATIONAL JOURNAL OF RHEUMATOLOGY.

Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis
Arefiev, K., Fiorentino, D. F., & Chung, L. (2011). Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis. INTERNATIONAL JOURNAL OF RHEUMATOLOGY.

Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis
Ferdowsi, N., Huq, M., Stevens, W., Hudson, M., Wang, M., Tay, T., … Fritzler, M. (2019). Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis. ANNALS OF THE RHEUMATIC DISEASES, 78(6), 807–16.

ABATACEPT IN EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS- RESULTS OF A PHASE 2 INVESTIGATOR-INITIATED, MULTICENTER, DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL
Khanna, D., Spino, C., Bush, E., Johnson, S., Chung, L., Denton, C., … Furst, D. (2019). ABATACEPT IN EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS- RESULTS OF A PHASE 2 INVESTIGATOR-INITIATED, MULTICENTER, DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL. ANNALS OF THE RHEUMATIC DISEASES. BMJ PUBLISHING GROUP.

SAFETY AND EFFICACY OF LENABASUM IN AN OPEN-LABEL EXTENSION OF A PHASE 2 STUDY IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS SUBJECTS (DCSSC)
Spiera, R., Hummers, L., Chung, L., Frech, T., Domsic, R., Hsu, V., … White, B. (2019). SAFETY AND EFFICACY OF LENABASUM IN AN OPEN-LABEL EXTENSION OF A PHASE 2 STUDY IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS SUBJECTS (DCSSC). ANNALS OF THE RHEUMATIC DISEASES, 78, 245.

Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort
Harel, D., Mills, S. D., Kwakkenbos, L., Carrier, M.-E., Nielsen, K., Portales, A., … Lambert, M. (2019). Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort. BMJ OPEN, 9(2), e024010.

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis - Results of a Phase 2 Investigator-Initiated, Multicenter, Double-Blind Randomized Placebo-Controlled Trial.
Khanna, D., Spino, C., Johnson, S., Chung, L., Whitfield, M., Denton, C. P., … Furst, D. E. (2019). Abatacept in Early Diffuse Cutaneous Systemic Sclerosis - Results of a Phase 2 Investigator-Initiated, Multicenter, Double-Blind Randomized Placebo-Controlled Trial. Arthritis & Rheumatology (Hoboken, N.J.).

Validation of the Body Concealment Scale for Scleroderma (BCSS): Replication in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort.
Jewett, L. R., Kwakkenbos, L., Carrier, M.-E. E., Malcarne, V. L., Harcourt, D., Rumsey, N., … Thombs, B. D. (2017). Validation of the Body Concealment Scale for Scleroderma (BCSS): Replication in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort. Body Image, 20, 99–106.

Microvascular hand surgery for digital ischemia in scleroderma
Satteson, E. S., Chung, M. P., Chung, L. S., & Chang, J. (2019). Microvascular hand surgery for digital ischemia in scleroderma. JOURNAL OF SCLERODERMA AND RELATED DISORDERS.

Preterm birth phenotypes in women with autoimmune rheumatic diseases: A population based cohort study.
Kolstad, K. D., Mayo, J. A., Chung, L., Chaichian, Y., Kelly, V. M., Druzin, M., … Simard, J. F. (2019). Preterm birth phenotypes in women with autoimmune rheumatic diseases: A population based cohort study. BJOG : an International Journal of Obstetrics and Gynaecology.

Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry.
Shanmugam, V. K., Frech, T. M., Steen, V. D., Hummers, L. K., Shah, A. A., Bernstein, E. J., … Assassi, S. (2019). Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry. Clinical Rheumatology.

Upper Extremity Angiographic Patterns in Systemic Sclerosis: Implications for Surgical Treatment
Leyden, J., Burn, M. B., Wong, V., Leon, D. S., Kaizawa, Y., Chung, L., & Chang, J. (2019). Upper Extremity Angiographic Patterns in Systemic Sclerosis: Implications for Surgical Treatment. JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 44(11).

HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry.
Gourh, P., Safran, S. A., Alexander, T., Boyden, S. E., Morgan, N. D., Shah, A. A., … Remmers, E. F. (2019). HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry. Proceedings of the National Academy of Sciences of the United States of America.

Late Breaking Abstract - Safety and efficacy of B-cell depletion with rituximab for the treatment of systemic sclerosis-associated pulmonary arterial hypertension
Zamanian, R., Badesch, D., Chung, L., Domsic, R., Medsger, T., Pinckney, A., … Nicolls, M. (2019). Late Breaking Abstract - Safety and efficacy of B-cell depletion with rituximab for the treatment of systemic sclerosis-associated pulmonary arterial hypertension. EUROPEAN RESPIRATORY JOURNAL. EUROPEAN RESPIRATORY SOC JOURNALS LTD.

Safety and Efficacy of B-cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension in a Multi-center NIH Clinical Trial
Nicolls, M., Badesch, D., Chung, L., Domsic, R., Medsger, T., Pinckney, A., … Zamanian, R. (2019). Safety and Efficacy of B-cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension in a Multi-center NIH Clinical Trial. ARTHRITIS & RHEUMATOLOGY. WILEY.

Change in Calcinosis over 1 Year Using the SCTC Radiologic Scoring System for Calcinosis of the Hands in Patients with Systemic Sclerosis
Valenzuela, A., Chung, M., Rodriguez-Reyna, T. S., Proudman, S., Baron, M., Castelino, F., … Chung, L. (2019). Change in Calcinosis over 1 Year Using the SCTC Radiologic Scoring System for Calcinosis of the Hands in Patients with Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 71.

Prevalence and Clinical Associations of Degos Lesions in Systemic Sclerosis
Song, P., Chung, M., Li, S., Fiorentino, D., & Chung, L. (2019). Prevalence and Clinical Associations of Degos Lesions in Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 71.

Cytokine Signatures Differentiate Systemic Sclerosis Patients at High versus Low Risk for Pulmonary Arterial Hypertension
Kolstad, K., Khatri, A., Donato, M., Chang, S., Li, S., Steen, V., … Chung, L. (2019). Cytokine Signatures Differentiate Systemic Sclerosis Patients at High versus Low Risk for Pulmonary Arterial Hypertension. ARTHRITIS & RHEUMATOLOGY. WILEY.

Aggregation of Functional Variants in NOTCH4 Gene Increases SSc Risk
Gourh, P., Safran, S., Alexander, T., Boyden, S., Shah, A., Mayes, M., … Remmers, E. (2019). Aggregation of Functional Variants in NOTCH4 Gene Increases SSc Risk. ARTHRITIS & RHEUMATOLOGY, 71.

The Collaborative National Quality and Efficacy Registry for Scleroderma: Data Completion Outcomes from a Multicenter United States Cohort Using Guideline-Based Registry Practices
Shanmugam, V., Frech, T., Steen, V., Hummers, L., Shah, A., Bernstein, E., … Assassi, S. (2019). The Collaborative National Quality and Efficacy Registry for Scleroderma: Data Completion Outcomes from a Multicenter United States Cohort Using Guideline-Based Registry Practices. ARTHRITIS & RHEUMATOLOGY, 71.

Development and Preliminary Validation of a Novel Lung Ultrasound Interpretation Criteria for the Detection of Interstitial Lung Disease in Patients with Systemic Sclerosis
Fairchild, R., Yang, D., Chung, M., Sharpless, L., Li, S., & Chung, L. (2019). Development and Preliminary Validation of a Novel Lung Ultrasound Interpretation Criteria for the Detection of Interstitial Lung Disease in Patients with Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY. WILEY.

Subsets in Systemic Sclerosis-ILD: Working Towards Consensus-Based Definitions
Roofeh, D., Brown, K., Tashkin, D., Assassi, S., Barratt, S., Bernstein, E., … Khanna, D. (2019). Subsets in Systemic Sclerosis-ILD: Working Towards Consensus-Based Definitions. ARTHRITIS & RHEUMATOLOGY, 71.

Ultrasound Detection of Calcinosis and Correlation with Ulnar Artery Occlusion in Patients with Systemic Sclerosis
Fairchild, R., Chung, M., Sharpless, L., Li, S., & Chung, L. (2019). Ultrasound Detection of Calcinosis and Correlation with Ulnar Artery Occlusion in Patients with Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY. WILEY.

Ultrasound Evaluation of the Hands in Patients with Systemic Sclerosis: Osteophytosis Is a Major Contributor to Tender Joints
Fairchild, R., Chung, M., Sharpless, L., Li, S., Hong, J., Sheth, K., & Chung, L. (2019). Ultrasound Evaluation of the Hands in Patients with Systemic Sclerosis: Osteophytosis Is a Major Contributor to Tender Joints. ARTHRITIS & RHEUMATOLOGY. WILEY.

Ancestry-Specific Classical HLA Alleles Define Phenotypic Subsets in the African American Scleroderma Population
Gourh, P., Safran, S., Boyden, S., Shah, A., Mayes, M., Doumatey, A., … Alexander, T. (2019). Ancestry-Specific Classical HLA Alleles Define Phenotypic Subsets in the African American Scleroderma Population. ARTHRITIS & RHEUMATOLOGY, 71.

Raynaud phenomenon and digital ulcers in systemic sclerosis.
Hughes, M., Allanore, Y., Chung, L., Pauling, J. D., Denton, C. P., & Matucci-Cerinic, M. (2020). Raynaud phenomenon and digital ulcers in systemic sclerosis. Nature Reviews. Rheumatology.

Developing classification criteria for skin-predominant dermatomyositis: the Delphi process
Concha, J. S. S., Pena, S., Gaffney, R. G., Patel, B., Tarazi, M., Kushner, C. J., … Werth, V. P. (2020). Developing classification criteria for skin-predominant dermatomyositis: the Delphi process. BRITISH JOURNAL OF DERMATOLOGY, 182(2), 410–17.

Drugs in phase I and phase II clinical trials for systemic sclerosis.
Chung, M. P., & Chung, L. (2020). Drugs in phase I and phase II clinical trials for systemic sclerosis. Expert Opinion on Investigational Drugs.

Increased Mortality in Asians With Systemic Sclerosis in Northern California.
Chung, M. P., Dontsi, M., Postlethwaite, D., Kesh, S., Simard, J. F., Fiorentino, D., … Chung, L. (2020). Increased Mortality in Asians With Systemic Sclerosis in Northern California. ACR Open Rheumatology.

Calcinosis biomarkers in and Juvenile Dermatomyositis.
Chung, M. P., Richardson, C., Kirakossian, D., Orandi, A. B., Saketkoo, L. A., Rider, L. G., … Chung, L. (2020). Calcinosis biomarkers in and Juvenile Dermatomyositis. Autoimmunity Reviews, 102533.

The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility Trial.
Carrier, M.-E. E., Kwakkenbos, L., Nielson, W. R., Fedoruk, C., Nielsen, K., Milette, K., … Thombs, B. D. (2020). The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility Trial. JMIR Research Protocols, 9(4), e16799.

Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with systemic sclerosis.
Spiera, R., Hummers, L., Chung, L., Frech, T. M., Domsic, R., Hsu, V., … White, B. (2020). Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with systemic sclerosis. Arthritis & Rheumatology (Hoboken, N.J.).

A Novel Utility to Correct for Plate/Batch/Lot and Nonspecific Binding Artifacts in Luminex Data.
Maecker, H. T., Rosenberg-Hasson, Y., Kolstad, K. D., Steen, V. D., & Chung, L. S. (2020). A Novel Utility to Correct for Plate/Batch/Lot and Nonspecific Binding Artifacts in Luminex Data. Journal of Immunology (Baltimore, Md. : 1950).

Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients.
Fortune, C., Gietzen, A., Guillot, G., Lewis, N., Nielsen, K., Richard, M., … Varga, J. (2020). Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients. Journal of Psychosomatic Research, 110132.

Ultrasound Detection of Calcinosis and Association with Ulnar Artery Occlusion in Patients with Systemic Sclerosis.
Fairchild, R., Chung, M., Sharpless, L., Li, S., & Chung, L. (2020). Ultrasound Detection of Calcinosis and Association with Ulnar Artery Occlusion in Patients with Systemic Sclerosis. Arthritis Care & Research.

Development and Assessment of a Novel Lung Ultrasound Interpretation Criteria for the Detection of Interstitial Lung Disease in Systemic Sclerosis.
Fairchild, R., Chung, M., Yang, D., Sharpless, L., Li, S., & Chung, L. (2020). Development and Assessment of a Novel Lung Ultrasound Interpretation Criteria for the Detection of Interstitial Lung Disease in Systemic Sclerosis. Arthritis Care & Research.

Digital ulcers: should debridement be a standard of care in systemic sclerosis?
Hughes, M., Alcacer-Pitarch, B., Allanore, Y., Baron, M., Boin, F., Bruni, C., … Matucci-Cerinic, M. (2020). Digital ulcers: should debridement be a standard of care in systemic sclerosis? LANCET RHEUMATOLOGY, 2(5), E302–E307.

CD47 prevents the elimination of diseased fibroblasts in scleroderma.
Lerbs, T., Cui, L., King, M. E., Chai, T., Muscat, C., Chung, L., … Wernig, G. (2020). CD47 prevents the elimination of diseased fibroblasts in scleroderma. JCI Insight, 5(16).

Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis.
Valenzuela, A., Baron, M., Rodriguez-Reyna, T. S., Proudman, S., Khanna, D., Young, A., … Chung, L. (2020). Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis. Seminars in Arthritis and Rheumatism, 50(5), 891–96.

Gastric antral vascular ectasia in systemic sclerosis: Association with anti-RNA polymerase III and negative anti-nuclear antibodies.
Serling-Boyd, N., Chung, M. P.-S., Li, S., Becker, L., Fernandez-Becker, N., Clarke, J., … Chung, L. (2020). Gastric antral vascular ectasia in systemic sclerosis: Association with anti-RNA polymerase III and negative anti-nuclear antibodies. Seminars in Arthritis and Rheumatism, 50(5), 938–42.

A Mortality Risk Score Model for Clinically Amyopathic Dermatomyositis-Associated Interstitial Lung Disease: Will It Have the Necessary "FLAIR" to Improve Clinical Outcomes?
Baker, M. C., Chung, L., & Fiorentino, D. F. (2020). A Mortality Risk Score Model for Clinically Amyopathic Dermatomyositis-Associated Interstitial Lung Disease: Will It Have the Necessary "FLAIR" to Improve Clinical Outcomes? Chest, 158(4), 1307–9.

Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes
Lescoat, A., Murphy, S. L., Roofeh, D., Pauling, J. D., Hughes, M., Sandler, R., … Khanna, D. (2020). Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes. JOURNAL OF SCLERODERMA AND RELATED DISORDERS.

Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?
Frech, T. M., VanBuren, J. M., Startup, E., Assassi, S., Bernstein, E. J., Castelino, F. V., … Evnin, L. (2020). Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures? Clinical Rheumatology.

Response to Mittal and Sharma Letter to the Editor.
Spiera, R., Chung, L., Frech, T., Domsic, R., Hsu, V., Furst, D., … White, B. (2020). Response to Mittal and Sharma Letter to the Editor. Arthritis & Rheumatology (Hoboken, N.J.).

Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis.
Liu, Q., Zaba, L., Satpathy, A. T., Longmire, M., Zhang, W., Li, K., … Chang, H. Y. (2020). Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis. Nature Communications, 11(1), 5843.

Efficacy and safety of nintedanib in Asian patients with systemic sclerosis-associated interstitial lung disease: Subgroup analysis of the SENSCIS trial.
Azuma, A., Chung, L., Behera, D., Chung, M., Kondoh, Y., Ogura, T., … Kuwana, M. (2020). Efficacy and safety of nintedanib in Asian patients with systemic sclerosis-associated interstitial lung disease: Subgroup analysis of the SENSCIS trial. Respiratory Investigation.

Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease-Associated Interstitial Lung Disease.
Zhu, L., Chung, M. P., Gagne, L., Guo, H. H., Guenther, Z., Li, S., … Chung, L. (2020). Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease-Associated Interstitial Lung Disease. ACR Open Rheumatology.

Increased Rates of Obstetric Complications Prior to Systemic Sclerosis Diagnosis.
Chung, M. P., Kolstad, K. D., Dontsi, M., Postlethwaite, D., Manwani, P., Zhao, H., … Chung, L. (2020). Increased Rates of Obstetric Complications Prior to Systemic Sclerosis Diagnosis. Arthritis Care & Research.

Author Correction: Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis.
Liu, Q., Zaba, L. C., Satpathy, A. T., Longmire, M., Zhang, W., Li, K., … Chang, H. Y. (2020). Author Correction: Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis. Nature Communications, 11(1), 6416.

Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial
Chung, L., Spino, C., McLain, R., Johnson, S. R., Denton, C. P., Molitor, J. A., … Khanna, D. (2020). Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial. LANCET RHEUMATOLOGY, 2(12), E743–E753.

Clinical Outcomes Among Participants with Diffuse Systemic Sclerosis Contracting COVID-19 During Clinical Studies of Lenabasum: A Case Series
Domsic, R., Chung, L., Molitor, J., Spiera, R., Bloom, B., White, B., & Dinh, Q. (2020). Clinical Outcomes Among Participants with Diffuse Systemic Sclerosis Contracting COVID-19 During Clinical Studies of Lenabasum: A Case Series. ARTHRITIS & RHEUMATOLOGY, 72.

African Ancestry-Specific Variants Regulate TGFB3 Expression in Systemic Sclerosis
Hartman, J., Conte, A., Borden, C., Kaundal, U., Zhao, Y., Safran, S., … Gourh, P. (2020). African Ancestry-Specific Variants Regulate TGFB3 Expression in Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 72.

Increased Rates of Obstetric Complications Prior to Systemic Sclerosis Diagnosis
Chung, M., Kolstad, K., Dontsi, M., Manwani, P., Zhao, H., Postlethwaite, D., … Chung, L. (2020). Increased Rates of Obstetric Complications Prior to Systemic Sclerosis Diagnosis. ARTHRITIS & RHEUMATOLOGY. WILEY.

A Pilot Study to Evaluate the Safety and Efficacy of Treprostinil in the Treatment of Calcinosis in Patients with Systemic Sclerosis
Chung, M., Valenzuela Vergara, A. M., Catanese, B., Li, S., Stevens, K., & Chung, L. (2020). A Pilot Study to Evaluate the Safety and Efficacy of Treprostinil in the Treatment of Calcinosis in Patients with Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 72.

Baseline Characteristics of Systemic Sclerosis (SSc) Patients with Restrictive Lung Disease in a Multi-Center United States Based Longitudinal Registry
Castelino, F., VanBuren, J., Startup, E., Assassi, S., Bernstein, E., Chung, L., … Steen, V. (2020). Baseline Characteristics of Systemic Sclerosis (SSc) Patients with Restrictive Lung Disease in a Multi-Center United States Based Longitudinal Registry. ARTHRITIS & RHEUMATOLOGY, 72.

Intergenic HLA Variants in African American Patients with Systemic Sclerosis Regulate Expression of HLA-DRB1
Kaundal, U., Hartman, J., Borden, C., Wang, J., Shah, A., Mayes, M., … Gourh, P. (2020). Intergenic HLA Variants in African American Patients with Systemic Sclerosis Regulate Expression of HLA-DRB1. ARTHRITIS & RHEUMATOLOGY, 72.

Chest CT Ordering Practices at Expert Scleroderma Centers in the United States
Bernstein, E., VanBuren, J., Assassi, S., Castelino, F., Chung, L., Correia, C., … Khanna, D. (2020). Chest CT Ordering Practices at Expert Scleroderma Centers in the United States. ARTHRITIS & RHEUMATOLOGY, 72.

Prevalence of a Diagnosis of Osteopenia/Osteoporosis Amongst Patients with Systemic Sclerosis and Identification of Associated Clinical Factors
Wang, G., Mar, D., Wu, J., Simard, J., Popat, R., & Chung, L. (2020). Prevalence of a Diagnosis of Osteopenia/Osteoporosis Amongst Patients with Systemic Sclerosis and Identification of Associated Clinical Factors. ARTHRITIS & RHEUMATOLOGY. WILEY.

Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study
Thombs, B. D., Kwakkenbos, L., Henry, R. S., Carrier, M.-E., Patten, S., Harb, S., … Ellis, K. (2020). Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study. JOURNAL OF PSYCHOSOMATIC RESEARCH, 139, 110262.

Long-Term Outcomes in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta-Analyses of Randomized, Controlled Trials and Observational Registries.
Khanna, D., Zhao, C., Saggar, R., Mathai, S. C., Chung, L. S., Coghlan, J. G., … McLaughlin, V. (2021). Long-Term Outcomes in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta-Analyses of Randomized, Controlled Trials and Observational Registries. Arthritis & Rheumatology (Hoboken, N.J.).

A Systematic Review and Meta-Analysis to Inform Cancer Screening Guidelines in Idiopathic Inflammatory Myopathies.
Oldroyd, A. G., Allard, A. B., Callen, J. P., Chinoy, H., Chung, L., Fiorentino, D., … Aggarwal, R. (2021). A Systematic Review and Meta-Analysis to Inform Cancer Screening Guidelines in Idiopathic Inflammatory Myopathies. Rheumatology (Oxford, England).

Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: A Multi-center, Double-blind, Randomized, Placebo-controlled Trial.
Zamanian, R. T., Badesch, D., Chung, L., Domsic, R. T., Medsger, T., Pinckney, A., … Nicolls, M. R. (2021). Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: A Multi-center, Double-blind, Randomized, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine.

A narrative review of imaging in calcinosis associated with systemic sclerosis.
Mar, D., Valenzuela, A., Stevens, K. J., Chung, L., & Fairchild, R. M. (2021). A narrative review of imaging in calcinosis associated with systemic sclerosis. Clinical Rheumatology.

Raynaud phenomenon and digital ulcers in systemic sclerosis (vol 16, pg 208, 2020)
Hughes, M., Allanore, Y., Chung, L., Pauling, J. D., Denton, C. P., & Matucci-Cerinic, M. (2021). Raynaud phenomenon and digital ulcers in systemic sclerosis (vol 16, pg 208, 2020). NATURE REVIEWS RHEUMATOLOGY.

Microvascular Hand Surgery for Digital Ischemia in Scleroderma.
Satteson, E. S., Chung, M. P., Chung, L. S., & Chang, J. (2020). Microvascular Hand Surgery for Digital Ischemia in Scleroderma. Journal of Scleroderma and Related Disorders, 5(2), 130–136.

Reply to: Multiple Manifestations of Systemic Sclerosis Affect Walk Distance.
Zamanian, R. T., Pinckney, A., Domsic, R. T., Medsger, T., Keyes-Elstein, L., Sweatt, A. J., … Chung, L. (2021). Reply to: Multiple Manifestations of Systemic Sclerosis Affect Walk Distance. American Journal of Respiratory and Critical Care Medicine.

Ultrasound evaluation of the hands and wrists in patients with systemic sclerosis: Osteophytosis is a major contributor to tender joints.
Fairchild, R., Horomanski, A., Sharpless, L., Chung, M., Li, S., Hong, J., … Chung, L. (2021). Ultrasound evaluation of the hands and wrists in patients with systemic sclerosis: Osteophytosis is a major contributor to tender joints. Seminars in Arthritis and Rheumatism, 51(4), 735–740.

Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis.
Liu, S., Chung, M. P., Ley, B., French, S., Elicker, B. M., Fiorentino, D. F., … Wolters, P. J. (2021). Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis. Thorax.

Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes.
Lescoat, A., Murphy, S. L., Roofeh, D., Pauling, J. D., Hughes, M., Sandler, R., … Khanna, D. (2021). Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes. Journal of Scleroderma and Related Disorders, 6(1), 66–76.

Promise and challenge of systemic sclerosis therapies.
Kawano, Y., & Chung, L. (2021). Promise and challenge of systemic sclerosis therapies. Nature Reviews. Rheumatology.

Management of Calcinosis Associated with Dermatomyositis
Chung, M., & Chung, L. (2019). Management of Calcinosis Associated with Dermatomyositis. CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 5(4), 242–257.

Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies.
Oldroyd, A. G., Allard, A. B., Callen, J. P., Chinoy, H., Chung, L., Fiorentino, D., … Aggarwal, R. (2021). Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford, England).

A Pilot Study to Evaluate the Safety and Efficacy of Treprostinil in the Treatment of Calcinosis in Systemic Sclerosis.
Chung, M. P., Valenzuela, A., Li, S., Catanese, B., Stevens, K., Fiorentino, D., … Chung, L. (2021). A Pilot Study to Evaluate the Safety and Efficacy of Treprostinil in the Treatment of Calcinosis in Systemic Sclerosis. Rheumatology (Oxford, England).

Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?
Valenzuela, A., & Chung, L. (2021). Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis? JOURNAL OF SCLERODERMA AND RELATED DISORDERS.

A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO).
Dumbrava, E. E., Dougan, M. L., Gupta, S., Cappelli, L., Katsumoto, T. R., Rahma, O. E., … Sharon, E. (2021). A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO). JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial.
Nordlund, J., Henry, R. S., Kwakkenbos, L., Carrier, M.-E., Levis, B., Nielson, W. R., … Thombs, B. D. (2021). The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial. Trials, 22(1), 856.

Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registry.
Castelino, F. V., VanBuren, J. M., Startup, E., Assassi, S., Bernstein, E. J., Chung, L., … Steen, V. (2021). Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registry. International Journal of Rheumatic Diseases.

Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial.
Chung, L., Spino, C., McLain, R., Johnson, S. R., Denton, C. P., Molitor, J. A., … Khanna, D. (2020). Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial. The Lancet. Rheumatology, 2(12), e743–e753.

Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography
Khanna, D., Distler, O., Cottin, V., Brown, K. K., Chung, L., Goldin, J. G., … Maher, T. M. (2022). Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography. JOURNAL OF SCLERODERMA AND RELATED DISORDERS.

Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence.
Fiorentino, D. F., Mecoli, C. A., Rosen, M. C., Chung, L. S., Christopher-Stine, L., Rosen, A., & Casciola-Rosen, L. (1800). Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence. The Journal of Clinical Investigation, 132(2).

Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension.
Kolstad, K. D., Khatri, A., Donato, M., Chang, S. E., Li, S., Steen, V. D., … Chung, L. (2022). Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension. Arthritis Research & Therapy, 24(1), 39.

Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosis.
Valenzuela, A., Stevens, K., Chung, M. P., Rodriguez-Reyna, T. S., Proudman, S., Baron, M., … Chung, L. (2022). Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosis. Seminars in Arthritis and Rheumatism, 53, 151980.

Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program.
Kwakkenbos, L., Ostbo, N., Carrier, M.-E., Nielson, W. R., Fedoruk, C., Levis, B., … Thombs, B. D. (2022). Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program. Pilot and Feasibility Studies, 8(1), 45.

Factors Impacting Likelihood of Discontinuing Immunosuppression in Adult Dermatomyositis: A Single-Center Study
Cho, S. K., Chung, L., & Fiorentino, D. (2021). Factors Impacting Likelihood of Discontinuing Immunosuppression in Adult Dermatomyositis: A Single-Center Study. ARTHRITIS & RHEUMATOLOGY. WILEY.

Initial Results from the Implementation of a National Hydroxychloroquine Safe Prescribing Dashboard Within the Veterans Health Administration
Montgomery, A., Tarasovsky, G., Ehiorobo, I., Whooley, M., Barton, J., Sheth, K., … Schmajuk, G. (2021). Initial Results from the Implementation of a National Hydroxychloroquine Safe Prescribing Dashboard Within the Veterans Health Administration. ARTHRITIS & RHEUMATOLOGY. WILEY.

Overall Survival in Patients with Systemic Autoimmune Diseases Following Lung or Heart-Lung Transplantation at a Single High-Volume Academic Transplant Center: A Comparative Cohort Study
Melehani, J., Li, S., Mooney, J., & Chung, L. (2021). Overall Survival in Patients with Systemic Autoimmune Diseases Following Lung or Heart-Lung Transplantation at a Single High-Volume Academic Transplant Center: A Comparative Cohort Study. ARTHRITIS & RHEUMATOLOGY. WILEY.

Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States
Bernstein, E., VanBuren, J., Assassi, S., Castelino, F., Chung, L., Correia, C., … Khanna, D. (2021). Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States. ARTHRITIS & RHEUMATOLOGY. WILEY.

Trends in Adverse Pregnancy Outcomes Among Women with Systemic Sclerosis in the United States
Kawano, Y., Kolstad, K., Li, S., Simard, J., & Chung, L. (2021). Trends in Adverse Pregnancy Outcomes Among Women with Systemic Sclerosis in the United States. ARTHRITIS & RHEUMATOLOGY. WILEY.

Gastrointestinal Perforation in a patient with Anti-nuclear Matrix Protein 2 Antibody Positive Dermatomyositis.
Valenzuela, A., Rieger, K. E., Blish, C. A., Chung, L., & Fiorentino, D. (2022). Gastrointestinal Perforation in a patient with Anti-nuclear Matrix Protein 2 Antibody Positive Dermatomyositis. Arthritis Care & Research.

Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?
Valenzuela, A., & Chung, L. (2022). Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis? Journal of Scleroderma and Related Disorders, 7(1), 7–23.

Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States.
Bernstein, E. J., Assassi, S., Castelino, F. V., Chung, L., Correia, C., Evnin, L. B., … Khanna, D. (2022). Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States. ACR Open Rheumatology.

Biological and clinical insights from a randomised phase II study of an anti-oncostatin M monoclonal antibody in systemic sclerosis.
Denton, C. P., Del Galdo, F., Khanna, D., Vonk, M. C., Chung, L., Johnson, S. R., … Reid, J. (2022). Biological and clinical insights from a randomised phase II study of an anti-oncostatin M monoclonal antibody in systemic sclerosis. Rheumatology (Oxford, England).

A Genomic Meta-Analysis of Clinical Variables and Their Association with Intrinsic Molecular Subsets in Systemic Sclerosis.
Franks, J. M., Toledo, D. M., Martyanov, V., Wang, Y., Huang, S., Wood, T. A., … Whitfield, M. L. (2022). A Genomic Meta-Analysis of Clinical Variables and Their Association with Intrinsic Molecular Subsets in Systemic Sclerosis. Rheumatology (Oxford, England).

Cessation of immunomodulatory medication use in dermatomyositis: a single center cohort study.
Cho, S. K., Casciola-Rosen, L., Kapoor, P., Chung, L., & Fiorentino, D. (2022). Cessation of immunomodulatory medication use in dermatomyositis: a single center cohort study. Arthritis Care & Research.

Calcinosis in dermatomyositis: Origins and possible therapeutic avenues.
Davuluri, S., Duvvuri, B., Lood, C., Faghihi-Kashani, S., & Chung, L. (2022). Calcinosis in dermatomyositis: Origins and possible therapeutic avenues. Best Practice & Research. Clinical Rheumatology, 101768.

High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey.
Bruni, C., Chung, L., Hoffmann-Vold, A. M., Assassi, S., Gabrielli, A., Khanna, D., … Distler, O. (2022). High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey. Clinical and Experimental Rheumatology.

Clinical Phenotypes of Patients with Systemic Sclerosis with Distinct Molecular Signatures in Skin.
Yang, M., Goh, V., Lee, J., Espinoza, M., Yuan, Y., Carns, M., … Hinchcliff, M. (2022). Clinical Phenotypes of Patients with Systemic Sclerosis with Distinct Molecular Signatures in Skin. Arthritis Care & Research.

Calcinosis in systemic sclerosis.
Davuluri, S., Lood, C., & Chung, L. (2022). Calcinosis in systemic sclerosis. Current Opinion in Rheumatology.

Systemic Sclerosis Associated Interstitial Lung Disease: A Conceptual Framework for Subclinical, Clinical, and Progressive Disease.
Roofeh, D., Brown, K. K., Kazerooni, E. A., Tashkin, D., Assassi, S., Martinez, F., … Khanna, D. (2022). Systemic Sclerosis Associated Interstitial Lung Disease: A Conceptual Framework for Subclinical, Clinical, and Progressive Disease. Rheumatology (Oxford, England).

Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.
Khanna, D., Distler, O., Cottin, V., Brown, K. K., Chung, L., Goldin, J. G., … Maher, T. M. (2022). Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography. Journal of Scleroderma and Related Disorders, 7(3), 168–178.

Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients.
Thombs, B. D., Kwakkenbos, L., Carrier, M.-E. E., Bourgeault, A., Tao, L., Harb, S., … Varga, J. (2020). Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients. Journal of Psychosomatic Research, 135, 110132.

High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey
Bruni, C., Chung, L., Hoffmann-Vold, A. M., Assassi, S., Gabrielli, A., Khanna, D., … SCTC Collaborator. (2022). High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 40(10), 1951–1955.

Extreme Phenotype Approach Identifies Rare Variants in Systemic Sclerosis and Dermatomyositis Patients with Severe Calcinosis
Davuluri, S., Kaundal, U., Lood, C., Kapoor, P., Kawano, Y., Dell'Orso, S., … Chung, L. (2022). Extreme Phenotype Approach Identifies Rare Variants in Systemic Sclerosis and Dermatomyositis Patients with Severe Calcinosis. ARTHRITIS & RHEUMATOLOGY. WILEY.

Cancer Screening Recommendations for Patients with Idiopathic Inflammatory Myopathy
Oldroyd, A., Callen, J., Chinoy, H., Chung, L., Fiorentino, D., Gordon, P., … Aggarwal, R. (2022). Cancer Screening Recommendations for Patients with Idiopathic Inflammatory Myopathy. ARTHRITIS & RHEUMATOLOGY. WILEY.

Performance of the 2016 ACR/EULAR Myositis Response Criteria in Adult Dermatomyositis and Polymyositis Therapeutic Trials and Consensus Profiles
Saygin, D., Kim, H., Douglas, C., Erman, B., Wilkerson, J., Mcgrath, J., … Rider, L. G. (2022). Performance of the 2016 ACR/EULAR Myositis Response Criteria in Adult Dermatomyositis and Polymyositis Therapeutic Trials and Consensus Profiles. ARTHRITIS & RHEUMATOLOGY. WILEY.

The Collaborative National Quality and Efficacy Registry for Scleroderma: Association of Resource Utilization and Gastrointestinal Tract Symptoms in Early Disease
Luebker, S., Frech, T., Assassi, S., Gordon, J., Bernstein, E., Steen, V., … Sandorfi, N. (2022). The Collaborative National Quality and Efficacy Registry for Scleroderma: Association of Resource Utilization and Gastrointestinal Tract Symptoms in Early Disease. ARTHRITIS & RHEUMATOLOGY. WILEY.

Long-term Follow-Up of Participants of the Phase II Study That Evaluated Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis (ASSET Trial)
Sarsam, N., Johnson, S. R., Chung, L., Kafaja, S., Pope, J., Domsic, R., … Khanna, D. (2022). Long-term Follow-Up of Participants of the Phase II Study That Evaluated Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis (ASSET Trial). ARTHRITIS & RHEUMATOLOGY. WILEY.

Functional NOTCH4 Variants Increase Notch Signaling and Susceptibility for Systemic Sclerosis
Kaundal, U., Stenson, E., Sahu, M., Thakur, K. K., Wang, J., Shah, A., … Gourh, P. (2022). Functional NOTCH4 Variants Increase Notch Signaling and Susceptibility for Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY. WILEY.

Test-retest Reliability for the Mawdsley Calcinosis Questionnaire for the Measurement of Calcinosis Burden in Patients with Systemic Sclerosis
Valenzuela, A., Russell, A.-M., Chung, L., Jensen, K., & Saketkoo, L. A. (2022). Test-retest Reliability for the Mawdsley Calcinosis Questionnaire for the Measurement of Calcinosis Burden in Patients with Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY. WILEY.

Systemic Sclerosis-Associated Class II HLA Alleles Restrict the Diversity of the CDR3 and the T Cell Receptor Repertoire in African American Patients
Kaundal, U., Borden, C., Oguz, C., Lu, J., Stenson, E., Shah, A., … Gourh, P. (2022). Systemic Sclerosis-Associated Class II HLA Alleles Restrict the Diversity of the CDR3 and the T Cell Receptor Repertoire in African American Patients. ARTHRITIS & RHEUMATOLOGY. WILEY.

Autoantibodies in Patients with Early Systemic Sclerosis in the Collaborative National Quality and Efficacy Registry
Bosso, A., Assassi, S., Frech, T., Gordon, J., Bernstein, E., Richardson, C., … Steen, V. (2022). Autoantibodies in Patients with Early Systemic Sclerosis in the Collaborative National Quality and Efficacy Registry. ARTHRITIS & RHEUMATOLOGY. WILEY.

Genome-wide Association Study in African American Systemic Sclerosis Patients Identifies a Novel Target - Transforming Growth Factor-beta 3 (TGF beta 3)
Kaundal, U., Hartman, J., Stenson, E., Safran, S., Borden, C., Sahu, M., … Gourh, P. (2022). Genome-wide Association Study in African American Systemic Sclerosis Patients Identifies a Novel Target - Transforming Growth Factor-beta 3 (TGF beta 3). ARTHRITIS & RHEUMATOLOGY. WILEY.

The Collaborative National Quality and Efficacy Registry for Scleroderma: Association of Medication Use on Gastrointestinal Tract Symptoms in Early Disease
Luebker, S., Frech, T., Assassi, S., Gordon, J., Bernstein, E., Steen, V., … Sandorfi, N. (2022). The Collaborative National Quality and Efficacy Registry for Scleroderma: Association of Medication Use on Gastrointestinal Tract Symptoms in Early Disease. ARTHRITIS & RHEUMATOLOGY. WILEY.

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Rahaghi, F. F., Hsu, V. M., Kaner, R. J., Mayes, M. D., Rosas, I. O., Saggar, R., … Khanna, D. (2023). Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respiratory Research, 24(1), 6.

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation.
Ayoglu, B., Donato, M., Furst, D. E., Crofford, L. J., Goldmuntz, E., Keyes-Elstein, L., … Utz, P. J. (2023). Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation. Annals of the Rheumatic Diseases.

Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis.
Domsic, R. T., Pokrzywinski, R., Stassek, L., Benton, W. W., Vampola, C.-L. L., Furst, D. E., … Khanna, D. (2023). Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis. ACR Open Rheumatology.

Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis.
Song, P., Li, S., Lewis, M. A., Fiorentino, D. F., & Chung, L. (2023). Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis. JAMA Dermatology.

Performance of the 2016 ACR-EULAR myositis response criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles.
Saygin, D., Kim, H., Douglas, C., Erman, B., Wilkerson, J., McGrath, J. A., … Rider, L. G. (2023). Performance of the 2016 ACR-EULAR myositis response criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles. Rheumatology (Oxford, England).

Patient Experience of Systemic Sclerosis-Related Calcinosis: An International Study Informing Clinical Trials, Practice, and the Development of the Mawdsley Calcinosis Questionnaire.
Saketkoo, L. A., Gordon, J. K., Fligelstone, K., Mawdsley, A., Chaudhry, H. A., Valenzuela, A., … Steen, V. D. (2023). Patient Experience of Systemic Sclerosis-Related Calcinosis: An International Study Informing Clinical Trials, Practice, and the Development of the Mawdsley Calcinosis Questionnaire. Rheumatic Diseases Clinics of North America, 49(2), 463–481.

CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization.
Luebker, S., Frech, T., Assassi, S., Skaug, B., Gordon, J. K., Lakin, K., … Sandorfi, N. (2023). CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization. Rheumatology (Oxford, England).

The type 1 interferon signature reflects multiple phenotypic and activity measures in dermatomyositis.
Tabata, M. M., Hodgkinson, L. M., Wu, T. T., Li, S., Huard, C., Zhao, S., … Fiorentino, D. (2023). The type 1 interferon signature reflects multiple phenotypic and activity measures in dermatomyositis. Arthritis & Rheumatology (Hoboken, N.J.).

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.
Spiera, R., Kuwana, M., Khanna, D., Hummers, L., Frech, T. M., Stevens, W., … Denton, C. P. (2023). Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis. Arthritis & Rheumatology (Hoboken, N.J.).

An Electronic Dashboard to Improve Dosing of Hydroxychloroquine Within the Veterans Health Care System: Time Series Analysis.
Montgomery, A., Tarasovsky, G., Izadi, Z., Shiboski, S., Whooley, M. A., Dana, J., … Schmajuk, G. (2023). An Electronic Dashboard to Improve Dosing of Hydroxychloroquine Within the Veterans Health Care System: Time Series Analysis. JMIR Medical Informatics, 11, e44455.

Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review.
Ross, L., Maltez, N., Hughes, M., Schoones, J. W., Baron, M., Chung, L., … Alunno, A. (2023). Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review. Rheumatology (Oxford, England).

Endothelial biomarkers of systemic sclerosis-associated pulmonary hypertension.
Lammi, M. R., Kolstad, K. D., Saketkoo, L. A., Khatri, A., Utz, P. J., Steen, V. D., & Chung, L. (2023). Endothelial biomarkers of systemic sclerosis-associated pulmonary hypertension. Arthritis Care & Research.

Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis.
Saketkoo, L. A., Valenzuela, A., Kim, S., McCann, L. J., Lood, C., Wahezi, D. M., … Chung, L. (2023). Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis. Rheumatology (Oxford, England).

Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry.
Luo, Y., Gordon, J., Xu, J., Kolstad, K. D., Chung, L., Steen, V. D., & Bernstein, E. J. (2023). Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry. Rheumatology (Oxford, England).

The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation.
Luebker, S., Frech, T. M., Assassi, S., Gordon, J. K., Bernstein, E. J., Steen, V. D., … Sandorfi, N. (2023). The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation. Clinical and Experimental Rheumatology.

Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States.
Kawano, Y., Kolstad, K. D., Li, S., Simard, J. F., & Chung, L. (2023). Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States. Seminars in Arthritis and Rheumatism, 63, 152252.

Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline.
Raghu, G., Montesi, S. B., Silver, R. M., Hossain, T., Macrea, M., Herman, D., … Ghazipura, M. (2023). Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine.

Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review.
Campochiaro, C., Suliman, Y. A., Hughes, M., Schoones, J. W., Giuggioli, D., Moinzadeh, P., … Alunno, A. (2023). Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review. Seminars in Arthritis and Rheumatism, 63, 152267.

Surgical management of digital ulcers in systemic sclerosis: A systematic literature review.
Suliman, Y. A., Campochiaro, C., Hughes, M., Schoones, J. W., Giuggioli, D., Moinzadeh, P., … Alunno, A. (2023). Surgical management of digital ulcers in systemic sclerosis: A systematic literature review. Seminars in Arthritis and Rheumatism, 63, 152266.

Calcinosis in systemic sclerosis.
Davuluri, S., Lood, C., & Chung, L. (2023). Calcinosis in systemic sclerosis. Current Opinion in Rheumatology.

The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation
Luebker, S., Frech, T. M., Assassi, S., Gordon, J. K., Bernstein, E. J., Steen, V. D., … Sandorfi, N. (2023). The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 41(8), 1632–1638.

DAVIX: a vascular outcome measure in systemic sclerosis
Kapoor, P., & Chung, L. (2023). DAVIX: a vascular outcome measure in systemic sclerosis. LANCET RHEUMATOLOGY, 5(10), E569–E570.

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical StudiesGroup (IMACS)initiative.
Oldroyd, A. G., Callen, J. P., Chinoy, H., Chung, L., Fiorentino, D., Gordon, P., … Aggarwal, R. (2023). International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical StudiesGroup (IMACS)initiative. Nature Reviews. Rheumatology.

DAVIX: a vascular outcome measure in systemic sclerosis.
Kapoor, P., & Chung, L. (2023). DAVIX: a vascular outcome measure in systemic sclerosis. The Lancet. Rheumatology, 5(10), e569–e570.

Digital ulcers: should debridement be a standard of care in systemic sclerosis?
Hughes, M., Alcacer-Pitarch, B., Allanore, Y., Baron, M., Boin, F., Bruni, C., … Matucci-Cerinic, M. (2020). Digital ulcers: should debridement be a standard of care in systemic sclerosis? The Lancet. Rheumatology, 2(5), e302–e307.

Xist ribonucleoproteins promote female sex-biased autoimmunity.
Dou, D. R., Zhao, Y., Belk, J. A., Zhao, Y., Casey, K. M., Chen, D. C., … Chang, H. Y. (2024). Xist ribonucleoproteins promote female sex-biased autoimmunity. Cell, 187(3), 733–749.e16.

Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.
Oldroyd, A. G., Callen, J. P., Chinoy, H., Chung, L., Fiorentino, D., Gordon, P., … Aggarwal, R. (2024). Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative. Nature Reviews. Rheumatology.

Xist Ribonucleoproteins Promote Female Sex-biased Autoimmunity
Dou, D., Zhao, Y., Belk, J., Zhao, Y., Casey, K., Chen, D., … Chang, H. (2023). Xist Ribonucleoproteins Promote Female Sex-biased Autoimmunity. ARTHRITIS & RHEUMATOLOGY. WILEY.

Initial Characterization of a Skin Symptom Questionnaire for Patients with Systemic Sclerosis
Yu, J. M., VanBuren, J., Child, A., Alvey, J., Mandl, L., Pinheiro, L., … Gordon, J. (2023). Initial Characterization of a Skin Symptom Questionnaire for Patients with Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY. WILEY.

Myositis and Its Mimics: Guideline Updates, MRI Characteristics, and New Horizons.
Zandee van Rilland, E. D., Yao, L., Stevens, K. J., Chung, L. S., Fiorentino, D. F., & Boutin, R. D. (2024). Myositis and Its Mimics: Guideline Updates, MRI Characteristics, and New Horizons. AJR. American Journal of Roentgenology.

Racial variability in immune responses only partially explains differential systemic sclerosis disease severity.
Kuchinad, K. E., Kim, J. S., Woods, A., Leatherman, G., Gutierrez-Alamillo, L., Mayes, M. D., … Shah, A. A. (2024). Racial variability in immune responses only partially explains differential systemic sclerosis disease severity. Annals of the Rheumatic Diseases.

Calcinosis in dermatomyositis.
Davuluri, S., Chung, L., & Lood, C. (2024). Calcinosis in dermatomyositis. Current Opinion in Rheumatology.

Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis
Velauthapillai, A., Bootsma, M. F. R., Bruni, C., Bergmann, C., Matucci-Cerinic, M., Launay, D., … Vonk, M. C. (2024). Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis. RHEUMATOLOGY.